Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Prostate Cancer,2016,NCI,5R01CA175491-04,,Improving prostate cancer screening by integration of SNPs with blood biomarkers,"KLEIN, ROBERT",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,$1
Prostate Cancer,2016,NCI,5R01CA154980-05,,Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression,"VARAMBALLY, SOORYANARAYANA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$305,025"
Prostate Cancer,2016,NIA,4K24AG041180-05,,Midcareer Mentoring Award for Patient-Oriented Research in Aging,"WALTER, LOUISE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$181,775"
Prostate Cancer,2016,NCI,5K24CA160653-05,,Midcareer Investigator Award,"FREEDLAND, STEPHEN",CEDARS-SINAI MEDICAL CENTER,CA,"$175,476"
Prostate Cancer,2016,NCI,1R35CA197465-01,,Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance,"RONAI, ZE'EV",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$1,162,978"
Prostate Cancer,2016,NCI,1R35CA197684-01,,"IKK/NF-kappaB Signaling in Cancer:  Therapy, Resistance, and Tumor Initiating Cells","BALDWIN, ALBERT",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$848,325"
Prostate Cancer,2016,NCI,1R35CA197566-01,,Mechanisms governing metastatic dormancy and reactivation,"GIANCOTTI, FILIPPO",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$959,998"
Prostate Cancer,2016,NCI,4R01CA079954-16,,Synthetic Regulators of Tyrosine Protein Kinases,"LAWRENCE, DAVID",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$288,131"
Prostate Cancer,2016,NCI,4P30CA006516-51,6052,Prostate Cancer,"KANTOFF, PHILIP",DANA-FARBER CANCER INST,MA,"$93,226"
Prostate Cancer,2016,NCI,4P30CA006516-51,6064,Cancer Epidemiology,"HANKINSON, SUSAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$82,450"
Prostate Cancer,2016,NCI,5R21CA185808-02,,Genetic Testing For Men From Hereditary Cancer Families,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$169,106"
Prostate Cancer,2016,NCI,5R01CA190289-02,,Compensatory steroidogenesis mechanisms in castration-resistant prostate cancer,"SHARIFI, NIMA",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$362,569"
Prostate Cancer,2016,NCI,5R01CA181605-03,,Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$351,588"
Prostate Cancer,2016,NCI,5R01CA183929-02,,Molecular mechanisms of prostate cancer metastasis,"ABATE-SHEN, CORY",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Prostate Cancer,2016,NCI,5R01CA181189-03,,Functional Role of Bone Marrow Adipocytes in Metastatic Prostate Cancer,"PODGORSKI, IZABELA",WAYNE STATE UNIVERSITY,MI,"$315,400"
Prostate Cancer,2016,NCI,5R21CA184646-02,,Managing prostate cancer metastasis using vitamin k2,"MUNIRATHINAM, GNANASEKAR",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$173,828"
Prostate Cancer,2016,NIBIB,4R01EB016034-04,,Non-invasive trapping and imaging of circulating tumor cells in the peripheral va,"O'DONNELL, MATTHEW",UNIVERSITY OF WASHINGTON,WA,"$442,239"
Prostate Cancer,2016,NCI,4R01CA160289-05,,Gene Therapy and Radiation Therapy for Prostate Cancer,"FREYTAG, SVEND",HENRY FORD HEALTH SYSTEM,MI,"$273,589"
Prostate Cancer,2016,NCI,4R01CA156775-06,,"Molecular Imaging Directed, 3D Ultrasound-guided, Biopsy System","FEI, BAOWEI",EMORY UNIVERSITY,GA,"$175,499"
Prostate Cancer,2016,NCI,4R01CA172220-04,,Estrogen Receptors in Human Prostate Stem-Progenitor Cells,"PRINS, GAIL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$330,527"
Prostate Cancer,2016,NCI,5K05CA175147-03,,Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention,"STANFORD, JANET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$88,959"
Prostate Cancer,2016,NIMHD,4R01MD006232-05,,Health Promotion for Positives: A Randomized Trial with HIV Positive Black Men,"JEMMOTT, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$399,065"
Prostate Cancer,2016,NCI,5P30CA008748-50,7555,Antitumor,"DE STANCHINA, ELISA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$222,125"
Prostate Cancer,2016,NCI,5P30CA008748-50,7564,Organic Sythesis,"OUERFELLI, OUATHEK",SLOAN-KETTERING INST CAN RESEARCH,NY,"$321,306"
Prostate Cancer,2016,NCI,5P30CA008748-50,7582,Bioinfomatics,"THOMPSON, CRAIG",SLOAN-KETTERING INST CAN RESEARCH,NY,"$860,681"
Prostate Cancer,2016,NIGMS,4R01GM101709-04,,Paxillin as a Liaison between Extranuclear and Intranuclear Steroid Signaling,"HAMMES, STEPHEN",UNIVERSITY OF ROCHESTER,NY,"$291,650"
Prostate Cancer,2016,NIGMS,5R01GM112846-02,,Multivalent higher-order complexes regulate ubiquitination in Hedgehog signaling,"MITTAG, TANJA",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$309,685"
Prostate Cancer,2016,NCI,4R01CA158027-05,,PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening,"WALSH, JUDITH","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$414,889"
Prostate Cancer,2016,NCI,5R01CA176401-03,,RB Function in Prostate Cancer Progression,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$431,269"
Prostate Cancer,2016,NCI,5R21CA190931-02,,ARD1-dependent Androgen Receptor Signaling in Prostate Cancer,"LIU, WANGUO",LSU HEALTH SCIENCES CENTER,LA,"$158,775"
Prostate Cancer,2016,NCI,5R21CA185787-02,,Statistical methods for transcriptome profiling from archival tumor samples,"TYEKUCHEVA, SVITLANA",DANA-FARBER CANCER INST,MA,"$221,863"
Prostate Cancer,2016,NCI,5R00CA172695-04,,Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrin,"EVANS, MICHAEL","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$241,072"
Prostate Cancer,2016,NCI,5R01CA192669-02,,Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancer,"LARNER, JAMES",UNIVERSITY OF VIRGINIA,VA,"$398,547"
Prostate Cancer,2016,NCI,5R01CA101753-12,,Anticarcinogenic Effect of ITCs Against Prostate Cancer,"SINGH, SHIVENDRA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$346,500"
Prostate Cancer,2016,NCI,4P50CA094056-16,7926,Imaging and Characterizating Stress responses in vivo with p21 Reporter Mice,"PIWNICA-WORMS, DAVID",WASHINGTON UNIVERSITY,MO,"$101,425"
Prostate Cancer,2016,NCI,5R01CA156776-07,,Chemoprevention of Prostate Cancer by Allspice Derived Polyphenol: Ericifolin,"LOKESHWAR, BAL",GEORGIA REGENTS UNIVERSITY,GA,"$307,152"
Prostate Cancer,2016,NCI,5R01CA181242-02,,Identification of DNA methylation markers for risk of metastasis in localized pro,"CHAO, CHUN",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$571,325"
Prostate Cancer,2016,NCI,5R21CA190588-02,,eIF2a phosphorylation as a novel druggable target in CRPC,"WOLF, DIETER",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$212,063"
Prostate Cancer,2016,NCI,4K07CA166462-04,,Impact of Cancer on Adherence in Diabetes,"LIN, JENNY",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$168,604"
Prostate Cancer,2016,NCI,2U24CA115102-11,,Clinical and Analytical Validation of Cancer Biomarkers,"CHAN, DANIEL",JOHNS HOPKINS UNIVERSITY,MD,"$648,000"
Prostate Cancer,2016,NCI,2U01CA086402-16,,San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR),"THOMPSON, IAN",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$100,000"
Prostate Cancer,2016,NCI,2U01CA152813-06,,Glycoprotein Biomarkers for  Early Detection of Aggressive Prostate Cancer,"ZHANG, HUI",JOHNS HOPKINS UNIVERSITY,MD,"$565,219"
Prostate Cancer,2016,NCI,2U01CA113913-11,,"Emory, Harvard & Univ. of Washington Prostate Cancer Biomarker Center","SANDA, MARTIN",EMORY UNIVERSITY,GA,"$930,297"
Prostate Cancer,2016,NCI,4R01CA166084-04,,Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors,"HERSHMAN, DAWN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$318,652"
Prostate Cancer,2016,NCI,5R21CA191009-02,,Androgen Receptor- and Myc-Mediated Glutamine Metabolism in Prostate Cancer,"FRIGO, DANIEL",UNIVERSITY OF HOUSTON,TX,"$169,769"
Prostate Cancer,2016,NCI,5R01CA182435-02,,Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis,"DATTA, KAUSTUBH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$344,269"
Prostate Cancer,2016,NCI,2P50CA140388-06A1,8545,Administrative Core,"LOGOTHETIS, CHRISTOPHER",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$310,853"
Prostate Cancer,2016,NCI,2P50CA140388-06A1,8546,Biostatistics and Bioinformatics,"DO, KIM-ANH",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$282,888"
Prostate Cancer,2016,NCI,2P50CA140388-06A1,8547,Biospecimen and Pathology,"TRONCOSO, PATRICIA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$272,016"
Prostate Cancer,2016,NCI,2P50CA140388-06A1,8548,Developmental Research Program,"THOMPSON, TIMOTHY",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$75,200"
Prostate Cancer,2016,NCI,2P50CA140388-06A1,8549,Career Enhancement Program,"GALLICK, GARY",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$75,200"
Prostate Cancer,2016,NCI,2P50CA140388-06A1,8550,Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC,"ALLISON, JAMES",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$322,278"
Prostate Cancer,2016,NCI,2P50CA140388-06A1,8551,Targeting Tumor Microenvironment-Induced Therapy Resistance in Prostate Cancer Bone Metastasis,"LIN, SUE-HWA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$299,235"
Prostate Cancer,2016,NCI,2P50CA140388-06A1,8552,Targeting Androgen Receptor and PARP for Synthetic Lethality in CRPC,"THOMPSON, TIMOTHY",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$328,821"
Prostate Cancer,2016,NCI,2P50CA140388-06A1,8553,"Mitochondria, MicroRNA, and Metabolites in Predicting Aggressive Prostate Cancer","WU, XIFENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$293,268"
Prostate Cancer,2016,NCI,2P30CA016086-40,8624,Rapid Case Ascertainment,"OLSHAN, ANDREW",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$99,516"
Prostate Cancer,2016,NCI,4P30CA012197-41,5488,Microarray Core,"CHEN, YONG",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$191,420"
Prostate Cancer,2016,NCI,5R01CA184208-02,,Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer,"FRIGO, DANIEL",UNIVERSITY OF HOUSTON,TX,"$349,759"
Prostate Cancer,2016,NIBIB,5R01EB016707-03,,Protein Biomarker Arrays for Personalized Treatment of Prostate Cancer,"RUSLING, JAMES",UNIVERSITY OF CONNECTICUT STORRS,CT,"$342,229"
Prostate Cancer,2016,NCI,1R01CA200551-01,,A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR,"PARK, SEAN",MAYO CLINIC ROCHESTER,MN,"$247,249"
Prostate Cancer,2016,NCI,4P30CA046934-28,8112,HORMONE RELATED MALIGNANCIES,"HOLT, JEFFREY",UNIVERSITY OF COLORADO DENVER,CO,"$31,021"
Prostate Cancer,2016,NCI,4R01CA174206-04,,Bioinformatics Tools for Genomic Analysis of Tumor and Stromal Pathways in Cancer,"PARMIGIANI, GIOVANNI",DANA-FARBER CANCER INST,MA,"$324,548"
Prostate Cancer,2016,NCI,5P30CA015704-41,5444,Research Program:  Prostate Cancer,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$69,377"
Prostate Cancer,2016,NCI,5R00CA175290-04,,An integrated approach to dissect the functional network of large non-coding RNA,"CHEN, YIWEN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$201,953"
Prostate Cancer,2016,NCI,5U01CA183027-03,,Integrative molecular imaging and sequencing of prostate cancer,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN,MI,"$399,969"
Prostate Cancer,2016,NCI,5R21CA175834-02,,Ephrin and Eph regulation of prostate stem cells - Resubmission - 1,"MOSCATELLI, DAVID",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$184,331"
Prostate Cancer,2016,NCI,1R01CA200611-01,,Developing therapeutics against resistance to the androgen-deprivation therapy,"YU, QIN",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$387,731"
Prostate Cancer,2016,NCI,4U01CA149556-05,,Signaling Pathway Alterations in the Racial Disparity of Prostate Cancer,"LEE, PENG",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$351,092"
Prostate Cancer,2016,NIMHD,4P20MD006988-05,5732,Immunoseroproteomics in Prostate Cancer: Focus on Health Disparities,"CASIANO, CARLOS",LOMA LINDA UNIVERSITY,CA,"$163,681"
Prostate Cancer,2016,NIMHD,4P20MD006988-05,5737,Community Engagement/Outreach Core,"DE LEON, MARINO",LOMA LINDA UNIVERSITY,CA,"$183,774"
Prostate Cancer,2016,NIGMS,5SC3GM112558-02,,Enzyme-Based Platform Technology for Cancers Utilizing PAM: Etiology of Novel Ami,"MCINTYRE, NEIL",XAVIER UNIVERSITY OF LOUISIANA,LA,"$100,718"
Prostate Cancer,2016,NCI,1R01CA200718-01,,A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials,"EGGLY, SUSAN",WAYNE STATE UNIVERSITY,MI,"$624,044"
Prostate Cancer,2016,NCI,1R01CA200787-01,,Development of small molecules for ERG ablation in prostate cancer,"KITTLER, RALF",UT SOUTHWESTERN MEDICAL CENTER,TX,"$369,718"
Prostate Cancer,2016,NCI,4R01CA127923-09,,IKK   and the Control of Prostate Cancer Metastasis,"KARIN, MICHAEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$257,099"
Prostate Cancer,2016,NCI,4R01CA176844-04,,The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer,"VASIOUKHIN, VALERI",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$362,148"
Prostate Cancer,2016,NCI,1R01CA200979-01,,RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER,"LAPI, SUZANNE",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$336,263"
Prostate Cancer,2016,NCI,1R01CA201430-01,,p53 Variants in Cancer Risk and Therapy,"MURPHY, MAUREEN",WISTAR INSTITUTE,PA,"$466,358"
Prostate Cancer,2016,NCI,5R01CA183965-03,,Role of TOP2B in generating complex genomic rearrangements in human cancer,"YEGNASUBRAMANIAN, SRINIVASAN",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Prostate Cancer,2016,NCI,1R01CA195476-01A1,,Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate Cancer,"KESHARI, KAYVAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$246,700"
Prostate Cancer,2016,NCI,5R01CA112226-07,,Transcription repression in prostate cancer,"LOGAN, SUSAN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$402,563"
Prostate Cancer,2016,NCI,5R01CA183857-03,,Exploiting drivers of androgen receptor signaling negative prostate cancer for pr,"TOMLINS, SCOTT",UNIVERSITY OF MICHIGAN,MI,"$321,625"
Prostate Cancer,2016,NCI,4R01CA168691-04,,Impact of Urologist Practice Structure on Prostate Cancer Care,"HOLLENBECK, BRENT",UNIVERSITY OF MICHIGAN,MI,"$362,271"
Prostate Cancer,2016,NCI,2R01CA157429-04A1,,Overcoming drug resistance of castration-resistant prostate cancer,"LIU, XIAOQI",PURDUE UNIVERSITY,IN,"$257,688"
Prostate Cancer,2016,NCI,5K22CA174841-02,,PSMA Targeted Docetaxel Loaded Magnetic Nanoparticles for Prostate Cancer Therapy,"YALLAPU, MURALI",UNIVERSITY OF TENNESSEE HEALTH SCI CTR,TN,"$161,695"
Prostate Cancer,2016,NCI,5R01CA186780-21,,Roles of EAF2 in androgen action in the prostate,"WANG, ZHOU",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$371,525"
Prostate Cancer,2016,NCI,5R01CA190554-02,,Osteocytes in prostate cancer bone metastasis,"KELLER, EVAN",UNIVERSITY OF MICHIGAN,MI,"$354,563"
Prostate Cancer,2016,NIMHD,4P60MD006900-05,6096,"Molecular Epidemiology of Prostate Cancer Outcomes: Genetics, Multilevel Environ","REBBECK, TIMOTHY",UNIVERSITY OF PENNSYLVANIA,PA,"$379,764"
Prostate Cancer,2016,NIMHD,4P60MD006900-05,6095,Building multi-level models to examine the relationship between obesity and pros,"ZEIGLER-JOHNSON, CHARNITA",UNIVERSITY OF PENNSYLVANIA,PA,"$256,038"
Prostate Cancer,2016,NIMHD,4P60MD006900-05,6097,Multidimensional access and prostate cancer treatment disparities,"ARMSTRONG, KATRINA",UNIVERSITY OF PENNSYLVANIA,PA,"$320,463"
Prostate Cancer,2016,NIMHD,4P60MD006900-05,6098,Administrative Core,"REBBECK, TIMOTHY",UNIVERSITY OF PENNSYLVANIA,PA,"$175,827"
Prostate Cancer,2016,NIMHD,4P60MD006900-05,6237,"PRoject Implementation, Dissemination, and Evaluation (PRIDE) Core","GLANZ, KAREN",UNIVERSITY OF PENNSYLVANIA,PA,"$115,466"
Prostate Cancer,2016,NIBIB,4R01EB016100-04,,Secretory Phospholipases sPLA2 and their Receptors for Delivering Nanoparticles,"ARNOLD, ROBERT",AUBURN UNIVERSITY AT AUBURN,AL,"$333,485"
Prostate Cancer,2016,NCI,1R01CA192894-01A1,,Enhancing anti-neoplastic activity of metformin in prostate cancer,"LIU, XIAOQI",PURDUE UNIVERSITY,IN,"$354,563"
Prostate Cancer,2016,NCI,4R01CA163273-05,,Omega-3 PUFA-gene interaction in prostate cancer,"CHEN, YONG",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$360,081"
Prostate Cancer,2016,NCI,5R21CA185003-02,,Racial differences in CYP1B1 polymorphisms and risks for prostate cancer,"TANAKA, YUICHIRO",NORTHERN CALIFORNIA INSTITUTE/RES/EDU,CA,"$166,714"
Prostate Cancer,2016,NCI,1R01CA202690-01,,Circadian Disruption and Risk of Prostate Cancer in a Multiethnic Cohort,"MUCCI, LORELEI",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$299,682"
Prostate Cancer,2016,NCI,4R01CA084487-14,,Infidelity of Cytosine Methylation and Human Cancer,"SOWERS, LAWRENCE",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$246,622"
Prostate Cancer,2016,NCI,5R01CA178431-03,,Function of the Stem Cell Transcription Factor Sox2 in Prostate Cancer,"VANDER GRIEND, DONALD",UNIVERSITY OF CHICAGO,IL,"$323,229"
Prostate Cancer,2016,NCI,5R01CA179100-03,,Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis,"RICKMAN, DAVID",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$428,881"
Prostate Cancer,2016,NCI,5R01CA193910-02,,Defining the epigenetic landscape in human prostate cancer,"FREEDMAN, MATTHEW",DANA-FARBER CANCER INST,MA,"$628,587"
Prostate Cancer,2016,NCI,4R01CA168601-04,,Novel roles of microRNA in androgen receptor signaling,"GAO, ALLEN",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$309,073"
Prostate Cancer,2016,NCI,4R01CA169524-04,,Role of RNF6 in survival signaling,"QIU, YUN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$318,513"
Prostate Cancer,2016,NCI,4R01CA154387-04,,Inhibiting serine protease-induced prostate cancer progression,"RADISKY, EVETTE",MAYO CLINIC  JACKSONVILLE,FL,"$325,287"
Prostate Cancer,2016,NCI,4R01CA147313-06,,Implementation of evidence-based cancer early detection in Black churches,"HOLT, CHERYL","UNIV OF MARYLAND, COLLEGE PARK",MD,"$350,075"
Prostate Cancer,2016,NCI,4R01CA125535-09,,Mechanism of beta-Catenin and APC-Regulated Transcription at Wnt Target Genes,"JONES, KATHERINE",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$452,288"
Prostate Cancer,2016,NCI,5R01CA172576-03,,Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents,"CHEN, CHING-SHIH",OHIO STATE UNIVERSITY,OH,"$319,550"
Prostate Cancer,2016,NCI,4R01CA174777-04,,AR Gene Rearrangements and AR Signaling in Prostate Cancer,"DEHM, SCOTT",UNIVERSITY OF MINNESOTA,MN,"$310,251"
Prostate Cancer,2016,NCI,4R01CA171189-04,,Bidirectional role of KLF5 in prostatic epithelial homeostasis and tumorigenesis,"DONG, JIN-TANG",EMORY UNIVERSITY,GA,"$323,700"
Prostate Cancer,2016,NIDDK,4R01DK076602-11,,Progenitor cells of the mouse prostate epithelium,"SHEN, MICHAEL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$460,037"
Prostate Cancer,2016,NIBIB,1R15EB020351-01A1,,Combinatorial Nanotherapeutic Approach for Advanced Prostate Cancer Treatment,"TARATULA, OLEH",OREGON STATE UNIVERSITY,OR,"$440,708"
Prostate Cancer,2016,NCI,1R01CA202814-01A1,,Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging,"STEINMETZ, NICOLE",CASE WESTERN RESERVE UNIVERSITY,OH,"$409,144"
Prostate Cancer,2016,NCI,1R15CA202757-01,,Role of the AR-ErbB3-Nrdp1 axis in mediating prostate cancer health disparities,"VINALL, RUTH",CALIFORNIA NORTHSTATE UNIVERSITY,CA,"$421,195"
Prostate Cancer,2016,NIMHD,4P20MD006901-05,6536,Barbers Against Prostate Cancer,"LUQUE, JOHN",GEORGIA SOUTHERN UNIVERSITY,GA,"$170,991"
Prostate Cancer,2016,NCI,4R01CA159945-05,,SWI/SNF dysregulation in development and disease,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$321,625"
Prostate Cancer,2016,NCI,1R21CA191913-01A1,,"Auger Electron Radiotherapy of Late-Stage, Castration-Resistant Prostate Cancer using a Brominated Dihydrotestosterone Analogue","VEACH, DARREN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$191,291"
Prostate Cancer,2016,NCI,1R21CA202214-01,,Detection of High Grade Prostate Cancer with Subharmonic Ultrasound Imaging,"HALPERN, ETHAN",THOMAS JEFFERSON UNIVERSITY,PA,"$209,434"
Prostate Cancer,2016,NCI,4R01CA154835-05,,Role of alpha6 beta1 Integrin in Prostate Cancer,"MIRANTI, CYNTHIA",VAN ANDEL RESEARCH INSTITUTE,MI,"$381,906"
Prostate Cancer,2016,NIGMS,5R01GM111084-02,,Structural and Mechanistic Studies of the Mitochondrial Protein Folding Machinery,"TSAI, FRANCIS",BAYLOR COLLEGE OF MEDICINE,TX,"$340,642"
Prostate Cancer,2016,NCI,1R21CA195313-01A1,,Magi2 in aggressive prostate cancer,"MARKER, PAUL",UNIVERSITY OF WISCONSIN-MADISON,WI,"$161,777"
Prostate Cancer,2016,NCI,1R01CA195732-01A1,,The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy,"LICHT, JONATHAN",UNIVERSITY OF FLORIDA,FL,"$343,125"
Prostate Cancer,2016,NCI,1R21CA202552-01,,Comparative Effectiveness of Genomics Assay for Active Surveillance Failure Prediction in African American Men:  the impact of genetic ancestry and socioeconomic status.,"MURPHY, ADAM",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$220,289"
Prostate Cancer,2016,NCI,5R44CA192451-02,,Clinical Evaluation of a Novel Prostate Cancer PET Diagnostic,"LANGTON-WEBSTER, BEATRICE","CANCER TARGETED TECHNOLOGY, LLC",WA,"$923,913"
Prostate Cancer,2016,NCI,1R01CA193739-01A1,,Novel targeted chemo/immunotherapy approach for localized and metastatic CaP,"BHAT, MOHAMMAD SALEEM",UNIVERSITY OF MINNESOTA,MN,"$351,227"
Prostate Cancer,2016,NCI,1R01CA193829-01A1,,Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT,"SMITH, GARY",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$392,306"
Prostate Cancer,2016,NIGMS,4SC1CA180212-04,,Role of CCL25-CCR9 in Prostate Cancer,"SINGH, SHAILESH",MOREHOUSE SCHOOL OF MEDICINE,GA,"$353,750"
Prostate Cancer,2016,NCI,5R01CA193481-02,,Sequence-specific Capture for Discovering Protein-IncRNA Interactions in Prostate Cancer,"SMITH, LLOYD",UNIVERSITY OF WISCONSIN-MADISON,WI,"$344,168"
Prostate Cancer,2016,NCI,1R01CA193678-01A1,,Hemostatic Factors Drive Prostate Cancer Pathogenesis,"PALUMBO, JOSEPH",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$356,850"
Prostate Cancer,2016,NIBIB,1R01EB020353-01A1,,Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation,"BASILION, JAMES",CASE WESTERN RESERVE UNIVERSITY,OH,"$668,936"
Prostate Cancer,2016,NCI,1R01CA193331-01A1,,"Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination thru Engagement in Mindfulness Education (REASSURE ME)","VICTORSON, DAVID",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$560,890"
Prostate Cancer,2016,NCI,1R01CA190636-01A1,,Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery,"NELSON, CHRISTIAN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$708,273"
Prostate Cancer,2016,NCI,1R01CA191002-01A1,,The role of PLK1 in prostate cancer,"FU, ZHENG",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$348,844"
Prostate Cancer,2016,NCI,4R01CA154586-05,,The anti-senescence activity of trefoil factor 1,"WANG, XIAO-FAN",DUKE UNIVERSITY,NC,"$316,621"
Prostate Cancer,2016,NCI,4R01CA163980-05,,"Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival","BLASBERG, RONALD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$470,514"
Prostate Cancer,2016,NCI,5R01CA136924-07,,Prostate Cancer Risk Enhancers,"FARNHAM, PEGGY",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$564,927"
Prostate Cancer,2016,NCI,1U01CA202958-01,,Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer,"BASANTA GUTIERREZ, DAVID",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$686,385"
Prostate Cancer,2016,NCI,4R01CA174798-04,,Endothelial-to-osteoblast transition in prostate cancer bone metastasis,"LIN, SUE-HWA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$332,000"
Prostate Cancer,2016,NCI,4R01CA165263-17,,Tyrosine Kinases and Prostate Cancer,"KUNG, HSING-JIEN",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$319,550"
Prostate Cancer,2016,NCI,5R01CA108614-10,,Novel targets that are deregulated by loss of PTEN,"JOHNSON, DEBORAH",BAYLOR COLLEGE OF MEDICINE,TX,"$288,103"
Prostate Cancer,2016,NCI,5K08CA175154-05,,Defining the role of eIF4F in metastatic castration resistant prostate cancer,"HSIEH, ANDREW",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$169,560"
Prostate Cancer,2016,NCI,4R01CA167079-05,,Development of Hsp90 inhibitors for the treatment of cancer,"BLAGG, BRIAN",UNIVERSITY OF KANSAS LAWRENCE,KS,"$312,354"
Prostate Cancer,2016,NCI,5F31CA195887-02,,The function of differential DNA methylation in aggressive prostate cancer,"BHASIN, JEFFREY",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$22,602"
Prostate Cancer,2016,NCI,4R01CA027607-36,,Stress Induction of Glucose Regulated Protein GRP78/BiP,"LEE, AMY",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$462,114"
Prostate Cancer,2016,NCI,4R01CA155169-05,,Understanding Resistance to Next Generation Antiandrogens,"SAWYERS, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$372,919"
Prostate Cancer,2016,NCI,4R01CA160902-05,,Advancement and Validation of Prostate Diffusion and Spectroscopic MRI,"MAIER, STEPHAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$492,649"
Prostate Cancer,2016,NCI,5R01CA187918-02,,Targeting the p110beta isoform of PI3 kinase in prostate cancer,"ROBERTS, THOMAS",DANA-FARBER CANCER INST,MA,"$554,053"
Prostate Cancer,2016,NCI,4R01CA140297-07,,Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer,"MANNE, SHARON",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$282,254"
Prostate Cancer,2016,NCI,4R01CA161503-05,,NAD+ metabolism in prostate cancer,"KRIDEL, STEVEN",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$309,819"
Prostate Cancer,2016,NCI,4R01CA168899-04,,Cooperative steroidogenic inhibition for treatment of advanced prostate cancer,"SHARIFI, NIMA",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$326,897"
Prostate Cancer,2016,NCI,5R21CA185087-02,,Prostate Cancer Gene Identification within Candidate Region in African Americans,"BOCK, CATHRYN",WAYNE STATE UNIVERSITY,MI,"$204,723"
Prostate Cancer,2016,NCI,4R01CA172384-04,,The Role of NOV (CCN3) in Prostate Cancer Progression,"YU, JINDAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,588"
Prostate Cancer,2016,NCI,1U01CA202939-01,,"Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer","KANTOFF, PHILIP",SLOAN-KETTERING INST CAN RESEARCH,NY,"$470,524"
Prostate Cancer,2016,NCI,5R21CA188792-02,,"Oxidized redox state, a new  potential biomarker for prostate cancer progression","CHAISWING, LUKSANA",UNIVERSITY OF KENTUCKY,KY,"$206,202"
Prostate Cancer,2016,NCI,5R01CA193837-02,,Defining the Role of ERG in Modulating the AR Cistrome and Antiandrogen Sensitivity,"SAWYERS, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$468,128"
Prostate Cancer,2016,NIGMS,5R01GM114306-02,,"Histone Lysine deMethylation: Structures, Inhibitions and Mechanisms","CHENG, XIAODONG",EMORY UNIVERSITY,GA,"$288,655"
Prostate Cancer,2016,NCI,5K99CA194287-02,,Investigation of luminal stem cells and castration resistance in prostate cancer,"SHIBATA, MAHO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$112,770"
Prostate Cancer,2016,NCI,5R01CA175779-04,,Phosphatidylserine Targeted Tumor Cell Lytic Peptoids,"UDUGAMASOORIYA, DAMITH",UNIVERSITY OF HOUSTON,TX,"$282,027"
Prostate Cancer,2016,NIGMS,5R01GM086596-06,,Activation of androgen biosynthesis and drug metabolism by cytochrome b5,"AUCHUS, RICHARD",UNIVERSITY OF MICHIGAN,MI,"$337,356"
Prostate Cancer,2016,NIDDK,4K01DK092366-05,,IGF-mediated survival and proliferation in inflamed prostate,"JERDE, TRAVIS",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$118,335"
Prostate Cancer,2016,NCI,4R01CA176671-04,,Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET,"LEWIS, JASON",SLOAN-KETTERING INST CAN RESEARCH,NY,"$631,257"
Prostate Cancer,2016,NCI,5R01CA123484-09,,Role of Oncogenic Kinase Pim-1 in Prostate Cancer,"ABDULKADIR, SARKI",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$284,744"
Prostate Cancer,2016,NCI,5F30CA196108-02,,Functional Investigation of the Mitochondrial Pyruvate Carrier in Prostate Cancer,"BADER, DAVID",BAYLOR COLLEGE OF MEDICINE,TX,"$41,438"
Prostate Cancer,2016,NCI,5R21CA195222-02,,Autoantibodies against micro RNA for Early Cancer Detection,"ZENG, GANG",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$167,475"
Prostate Cancer,2016,NCI,5R21CA195694-02,,Targeting Pancreatic Cancer with Novel Mnk-eIF4E and AR Modulating Agents,"NJAR, VINCENT",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$179,403"
Prostate Cancer,2016,NCI,5R21CA185213-02,,Germline Mutations in African American Families with Aggressive Prostate Cancer,"LIU, WANGUO",LSU HEALTH SCIENCES CENTER,LA,"$158,775"
Prostate Cancer,2016,NCI,5R01CA181802-03,,Effect of Aerobic Exercise  on Genomic Signatures of Prostate Cancer Prognosis,"CHAN, JUNE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,$1
Prostate Cancer,2016,NIBIB,4R01EB016072-04,,Light Activation of Enzyme Inhibition,"KODANKO, JEREMY",WAYNE STATE UNIVERSITY,MI,"$368,623"
Prostate Cancer,2016,NCI,1R01CA196232-01A1,,Effectors of protein kinase C-mediated tumor progression,"KAZANIETZ, MARCELO",UNIVERSITY OF PENNSYLVANIA,PA,"$389,662"
Prostate Cancer,2016,NIMHD,5R01MD008934-03,,Decision Aids to Address Prostate Cancer Disparities in Minority Men,"TILBURT, JON",MAYO CLINIC ROCHESTER,MN,"$359,003"
Prostate Cancer,2016,NCI,4R01CA125612-08,,Towards Understanding Prostate Cancer Heterogeneity,"RUBIN, MARK",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$373,464"
Prostate Cancer,2016,NIMHD,5G12MD007590-29,,CANCER RESEARCH INFRASTRUCTURE DEVELOPMENT,"KHAN, SHAFIQ",CLARK ATLANTA UNIVERSITY,GA,"$1,843,123"
Prostate Cancer,2016,NCI,4R01CA155693-05,,Decoding NanogP8 in Tumorigenesis,"TANG, DEAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$99,292"
Prostate Cancer,2016,NCI,5R01CA189765-02,,CXCL13: a mediator of prostate cancer progression,"KAZANIETZ, MARCELO",UNIVERSITY OF PENNSYLVANIA,PA,"$356,098"
Prostate Cancer,2016,NIEHS,5R01ES014032-07,,Cancer in adults following in utero and early life exposure to arsenic,"STEINMAUS, CRAIG",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$443,622"
Prostate Cancer,2016,NCI,4R01CA157372-05,,VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer,"THAKUR, MATHEW",THOMAS JEFFERSON UNIVERSITY,PA,"$490,625"
Prostate Cancer,2016,NCI,5R00CA160640-04,,Tracing the origins of chromosomal translocations in prostate cancer,"MANI, RAM",UT SOUTHWESTERN MEDICAL CENTER,TX,"$248,999"
Prostate Cancer,2016,NCI,5U01CA185490-03,,Molecular determinant of racial disparity in prostate cancer,"SINGH, AJAY",UNIVERSITY OF SOUTH ALABAMA,AL,"$314,363"
Prostate Cancer,2016,NCI,5R21CA187354-02,,CHD1 and TAK1 Synthetic Lethality in Prostate Cancer,"CRAMER, SCOTT",UNIVERSITY OF COLORADO DENVER,CO,"$202,928"
Prostate Cancer,2016,NCI,1R43CA203420-01,,Targeting galectin-3 for prostate cancer therapy,"AHMED, HAFIZ","GLYCOMANTRA, INC.",VA,"$224,881"
Prostate Cancer,2016,NCI,1R44CA203199-01,,Novel Androgen Receptor Degraders to Treat Castration-Resistant Prostate Cancer,"WINKLER, JAMES","ARVINAS, INC.",CT,"$648,400"
Prostate Cancer,2016,NCI,5R01CA184012-03,,Bipolar Androgen Therapy for Progressive Castrate Resistant Prostate Cancer,"DENMEADE, SAMUEL",JOHNS HOPKINS UNIVERSITY,MD,"$261,450"
Prostate Cancer,2016,NCI,1F30CA203517-01,,Role of Neutrophil Elastase in Castration-Sensitive and Resistant Prostate Cancer,"LERMAN, IRINA",UNIVERSITY OF ROCHESTER,NY,"$48,576"
Prostate Cancer,2016,NCI,1F32CA196080-01A1,,Investigating the role of autophagy in Tak1 null prostate cancer and TRAIL sensitivity,"GOODALL, MEGAN",UNIVERSITY OF COLORADO DENVER,CO,"$56,118"
Prostate Cancer,2016,NCI,4R01CA166766-05,,Ascorbate-based biomarkers for predicting radiation response in prostate cancer,"WILSON, DAVID","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$485,743"
Prostate Cancer,2016,NCI,5R21CA191052-02,,Carbon-11 Labeled Sarcosine:  Mechanism of Action and Initial Performance in Prostate Cancer,"PIERT, MORAND",UNIVERSITY OF MICHIGAN,MI,"$170,455"
Prostate Cancer,2016,NIGMS,5R01GM110019-02,,Molecular mechanism of mTORC1-dependent translation and ribosome biogenesis,"INOKI, KEN",UNIVERSITY OF MICHIGAN,MI,"$289,707"
Prostate Cancer,2016,NCI,1R01CA196947-01A1,,Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery,"FIGUEIREDO, MARXA",PURDUE UNIVERSITY,IN,"$361,974"
Prostate Cancer,2016,NCI,1F30CA203472-01,,Clinical bacterial isolate engineered as an immunotherapy for prostate cancer,"ANKER, JONATHAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$48,576"
Prostate Cancer,2016,NCI,1F32CA203473-01,,The development of radiolabeled probes for imaging and therapy which target the chemokine CXCR4,"AMOR-COARASA, ALEJANDRO",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$56,118"
Prostate Cancer,2016,NCI,4R01CA132641-18,,The Biology of Prostate Stem Cells - Resubmission - 1,"WILSON, ELAINE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$394,769"
Prostate Cancer,2016,NCI,5R01CA184228-03,,Small Molecule PSMA-Targeted Alpha Therapy,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$404,015"
Prostate Cancer,2016,NCI,4R01CA115746-09,,Characterizing Prostate Cancer By ex vivo MRS Signatures,"CHENG, LEO",MASSACHUSETTS GENERAL HOSPITAL,MA,"$556,388"
Prostate Cancer,2016,NCI,5R01CA183882-02,,HCS to Identify Inhibitors and Disruptors of AR-TIF2 Interactions,"JOHNSTON, PAUL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$350,826"
Prostate Cancer,2016,NCI,5R01CA188427-02,,Regulation of tyrosine kinase signaling through interaction with membrane lipids,"TYNER, ANGELA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$430,265"
Prostate Cancer,2016,NCI,5R01CA188015-02,,Discovery of Selective MAP2K4 Inhibitors to Target Metastasis,"SCHEIDT, KARL",NORTHWESTERN UNIVERSITY,IL,"$346,802"
Prostate Cancer,2016,NCI,4R01CA159856-05,,Mechanisms of Carcinoma Differentiation and Invasion,"MERCURIO, ARTHUR",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$347,563"
Prostate Cancer,2016,NCI,5R01CA168393-03,,SOX9 Mediation of AR and ERG Driven Prostate Cancer,"BALK, STEVEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$361,050"
Prostate Cancer,2016,NCI,4R01CA169300-04,,Targeting Cathepsin L: A Novel Strategy to Impede Prostate and Breast Cancer Meta,"SIEMANN, DIETMAR",UNIVERSITY OF FLORIDA,FL,"$311,250"
Prostate Cancer,2016,NCI,5R01CA167966-05,,Prostate Cancer Recurrence:  models and mechanisms,"ABDULKADIR, SARKI",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$362,601"
Prostate Cancer,2016,NCI,5U01CA185148-02,,MIC-1 and its functional partners in prostate cancer racial disparity,"BATRA, SURINDER",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$312,080"
Prostate Cancer,2016,NCI,5R01CA192402-02,,Estimating Overdiagnosis in Cancer Screening Studies,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$535,700"
Prostate Cancer,2016,NIBIB,4R01EB013427-04,,New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI,"VIGNERON, DANIEL","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$712,949"
Prostate Cancer,2016,NCI,5R01CA178338-03,,Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer,"GIOELI, DANIEL",UNIVERSITY OF VIRGINIA,VA,"$327,850"
Prostate Cancer,2016,NCI,5R44CA176892-03,,Buoyancy based bioseparations,"SHI, GUIXIN","DIAGNOLOGIX, LLC",CA,"$500,000"
Prostate Cancer,2016,NIEHS,4R01ES022071-05,,Effects of Arsenic on Human Prostate Stem Cells and Prostate Cancer Risk,"PRINS, GAIL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$405,450"
Prostate Cancer,2016,NIGMS,5SC3GM109332-03,,Polymer-drug Conjugate Micelles for Treating Resistant Prostate Cancers,"LI, FENG",HAMPTON UNIVERSITY,VA,"$111,000"
Prostate Cancer,2016,NCI,4R01CA166588-05,,"MiR-183-96-182 cluster, prostatic zinc homeostasis and carcinogenesis","NONN, LARISA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$377,072"
Prostate Cancer,2016,NCI,7R01CA168517-05,,Mcl-1 in apoptosis and signal transduction: a structure/function approach,"PELLECCHIA, MAURIZIO",UNIVERSITY OF CALIFORNIA RIVERSIDE,CA,"$474,252"
Prostate Cancer,2016,NCI,5R01CA177984-03,,MicroRNAs in frequently deleted loci regulate prostate cancer EMT and metastasis,"SAINI, SHARANJOT",NORTHERN CALIFORNIA INSTITUTE/RES/EDU,CA,"$383,250"
Prostate Cancer,2016,NCI,5R01CA185297-02,,The aberrant androgen receptor underlies abiraterone/enzalutamide resistance,"LUO, JUN",JOHNS HOPKINS UNIVERSITY,MD,"$370,575"
Prostate Cancer,2016,NIGMS,5P20GM109091-03,8002,Targeting COPZl in miR-152 deficient tumor cells,"SHTUTMAN, MICHAEL",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,"$217,117"
Prostate Cancer,2016,NCI,4R01CA179129-04,,Bone metabolism and bone metastases in prostate cancer,"WILSON, KATHRYN",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$259,390"
Prostate Cancer,2016,NCI,4R01CA172886-04,,Inhibition of the tumor-promoting effects of TGF-beta in advanced prostate cancer,"SUN, LUZHE",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$310,213"
Prostate Cancer,2016,NCI,5R01CA185509-03,,(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc,"GHOSH, PARAMITA",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$258,128"
Prostate Cancer,2016,NCI,5R21CA195424-02,,Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer,"RYAN, CHARLES","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$207,124"
Prostate Cancer,2016,NCI,7R01CA172169-04,,PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM,"LU, JUNXUAN",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$332,401"
Prostate Cancer,2016,NCI,5R21CA194469-02,,(PQ3) AGEs and Race Specific Tumor Immune Response in Prostate Cancer,"TURNER, DAVID",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$140,445"
Prostate Cancer,2016,NCI,4R01CA169774-05,,Detection of in vivo enzyme activities with CEST MRI,"PAGEL, MARK",UNIVERSITY OF ARIZONA,AZ,"$457,208"
Prostate Cancer,2016,NHLBI,4R01HL058984-17,,Enzymology of H2S Biogenesis,"BANERJEE, RUMA",UNIVERSITY OF MICHIGAN,MI,"$349,928"
Prostate Cancer,2016,NCI,4R01CA160685-04,,Hsp60 regulation of apoptosis in prostate cancer,"CHANDRA, DHYAN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$252,894"
Prostate Cancer,2016,NIMHD,4P20MD002285-10,8562,Administrative Core,"KHAN, SHAFIQ",CLARK ATLANTA UNIVERSITY,GA,"$161,467"
Prostate Cancer,2016,NIMHD,4P20MD002285-10,8563,Research Core,"KHAN, SHAFIQ",CLARK ATLANTA UNIVERSITY,GA,"$161,467"
Prostate Cancer,2016,NIMHD,4P20MD002285-10,8565,Community Engagement/Outreach Core,"DAVIS, KIMBERLY",CLARK ATLANTA UNIVERSITY,GA,"$161,467"
Prostate Cancer,2016,NIMHD,4P20MD002285-10,8566,TGF BETA Signaling in Prostate Cancer Cells,"KHAN, SHAFIQ",CLARK ATLANTA UNIVERSITY,GA,"$161,467"
Prostate Cancer,2016,NIMHD,4P20MD002285-10,8567,Altered Immune/Inflammatory Pathway in Racially Diverse Prostate Cancers,"CHAUDHARY, JAIDEEP",CLARK ATLANTA UNIVERSITY,GA,"$161,466"
Prostate Cancer,2016,NIMHD,4P20MD002285-10,8568,Snail Signalling in Human Prostate Cancer,"ODERO-MARAH, VALERIE",CLARK ATLANTA UNIVERSITY,GA,"$161,466"
Prostate Cancer,2016,NIMHD,4P20MD002285-10,8574,Training Core,"CHAUDHARY, JAIDEEP",CLARK ATLANTA UNIVERSITY,GA,"$161,466"
Prostate Cancer,2016,NCI,4R01CA180277-04,,(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer,"LI, XIN",NEW YORK UNIVERSITY,NY,"$307,375"
Prostate Cancer,2016,NCI,4R01CA157809-05,,Tele-based Psychosocial Intervention for Symptom Management & HRQOL in Men Living,"PENEDO, FRANK",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$433,060"
Prostate Cancer,2016,NCI,4R01CA172801-04,,Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards,"KARCZMAR, GREGORY",UNIVERSITY OF CHICAGO,IL,"$464,511"
Prostate Cancer,2016,NIGMS,4R01GM084027-09,,Genetically Encoded Sensors Shed Light on Zinc Homeostasis,"PALMER, AMY",UNIVERSITY OF COLORADO,CO,"$280,304"
Prostate Cancer,2016,NCI,2R44CA192927-04A1,,Clinical Development of a Novel PET Imaging Agent for Prostate Cancer,"SATPAYEV, DAULET","IMAGINAB, INC.",CA,"$1,000,000"
Prostate Cancer,2016,NICHD,4R01HD074511-05,,Host Factors Influencing HIV Viral Load and Infectivity in Semen,"PILCHER, CHRISTOPHER","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$612,052"
Prostate Cancer,2016,NCI,5R00CA166507-04,,Molecular basis of androgen receptor mediated gene transcriptional repression,"CAI, CHANGMENG",UNIVERSITY OF MASSACHUSETTS BOSTON,MA,"$242,182"
Prostate Cancer,2016,NCI,4R01CA025836-36,,Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers,"KATZENELLENBOGEN, JOHN",UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,IL,"$419,409"
Prostate Cancer,2016,NCI,5R01CA179059-03,,Enhancement of BB2r-Targeted Radiotherapy for Prostate Cancer Utilizing Hypoxia-S,"GARRISON, JERED",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$312,288"
Prostate Cancer,2016,NCI,4R01CA173481-04,,Preclinical analyses of advanced prostate cancer in genetically-engineered mice,"ABATE-SHEN, CORY",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$389,781"
Prostate Cancer,2016,NCI,5P30CA016056-39,8364,Genitourinary Cancers Program,"TRUMP, DONALD",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$70,515"
Prostate Cancer,2016,NCI,5P30CA016056-39,8380,Mouse Tumor Model Shared Resource,"TRUMP, DONALD",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$102,861"
Prostate Cancer,2016,NCI,5R01CA184075-02,,PALS: Prostate Cancer Active Lifestyle Study,"WRIGHT, JONATHAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$648,228"
Prostate Cancer,2016,NCI,5R21CA185993-02,,Defining aberrant steroid elimination in castration resistant prostate cancer,"SIMPSON, MELANIE",UNIVERSITY OF NEBRASKA LINCOLN,NE,"$150,766"
Prostate Cancer,2016,NCI,4R01CA116337-10,,Molecular Signatures of Lethal and Indolent Prostate Cancer,"RUBIN, MARK",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$422,121"
Prostate Cancer,2016,NCI,5R01CA177771-03,,Tissue Specific Regulation of Diabetes-Associated Cancer Growth,"STENINA, OLGA",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$328,888"
Prostate Cancer,2016,NCI,5R01CA181654-02,,Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy,"NARLA, GOUTHAM",CASE WESTERN RESERVE UNIVERSITY,OH,"$374,305"
Prostate Cancer,2016,NCI,5R01CA195505-02,,Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer,"MARKS, LEONARD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$352,275"
Prostate Cancer,2016,NCI,7R21CA195607-02,,Hiring Non-toxic Virus Nanoparticles to Count Cancer Biomarker Molecules,"MAO, CHUANBIN",UNIVERSITY OF OKLAHOMA NORMAN,OK,"$195,175"
Prostate Cancer,2016,NCI,5R21CA178324-02,,Pim 1 Protein Kinase in Regulating Stromal Cell Biology in Prostate Cancer,"KRAFT, ANDREW",UNIVERSITY OF ARIZONA,AZ,"$166,886"
Prostate Cancer,2016,NCI,4P30CA056036-17,7223,Biology of Prostate Cancer,"PESTELL, RICHARD",THOMAS JEFFERSON UNIVERSITY,PA,"$27,080"
Prostate Cancer,2016,NHGRI,1R01HG008126-01A1,,Prioritizing rare variants associated with cancer using non-coding annotation,"GERSTEIN, MARK",YALE UNIVERSITY,CT,"$836,728"
Prostate Cancer,2016,NCI,1P01CA203628-01,7230,Project 1: Acid Ceramidase-S1P Metabolic Axis and Regulation of Tumor Resistance to Apoptosis,"VOELKEL-JOHNSON, CHRISTINA",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$271,517"
Prostate Cancer,2016,NIGMS,1SC2CA211027-01,,Influence of Androgen Deprivation and Tumor Microenvironment on Epigenetic Silencing of Tumor Metastasis Suppressor KISS1 during Prostate Cancer Progression,"WANG, HONGHE",TUSKEGEE UNIVERSITY,AL,"$147,000"
Prostate Cancer,2016,NCI,1R43CA203675-01,,Silk-Based Blood Sample Stabilization for Prostate Cancer Diagnostics,"KLUGE, JONATHAN","VAXESS TECHNOLOGIES, INC.",MA,"$223,416"
Prostate Cancer,2016,NCI,4R01CA157792-05,,Role of Inflammatory Neutrophils and their Unique MMP-9 in Tumor Progression,"QUIGLEY, JAMES",SCRIPPS RESEARCH INSTITUTE,CA,"$399,438"
Prostate Cancer,2016,NCI,5F30CA192896-02,,IL-1b-mediated tumor-stromal interaction and prostate cancer cell cooperation in the bone metastatic niche,"SHAHRIARI, KRISTINA",DREXEL UNIVERSITY,PA,"$42,847"
Prostate Cancer,2016,NCI,1R01CA205001-01,,Histologic and Immunohistochemical Biomarkers for Heavily Treated Metastatic Prostate Cancer.,"HUANG, JIAOTI",DUKE UNIVERSITY,NC,"$271,066"
Prostate Cancer,2016,NIMHD,5R01MD007105-05,,Biological and Environmental modifiers of Vitamin D3 and Prostate Cancer Risk,"KITTLES, RICK",UNIVERSITY OF ARIZONA,AZ,"$383,229"
Prostate Cancer,2016,NCI,4R01CA174714-04,,The role of IL-17 in prostate cancer,"YOU, ZONGBING",TULANE UNIVERSITY OF LOUISIANA,LA,"$312,288"
Prostate Cancer,2016,NIAAA,1R01AA024770-01,,"A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.","FERRARI, PIETRO",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$513,904"
Prostate Cancer,2016,NCI,1R01CA205058-01,,Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy,"GILL, INDERBIR",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$595,520"
Prostate Cancer,2016,NCI,5R21CA183679-02,,Microfluidic Western Blotting for Targeted Proteomic Analysis of Single Circulating Tumor Cells,"HERR, AMY",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$222,674"
Prostate Cancer,2016,NCI,4P30CA046592-28,6455,Cancer Genetics,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$241,479"
Prostate Cancer,2016,NCI,4P30CA046592-28,6457,Molecular Imaging,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$142,546"
Prostate Cancer,2016,NCI,4P30CA046592-28,6460,Prostate Oncology,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$281,493"
Prostate Cancer,2016,NCI,5R21CA187843-02,,Role of Axl in docetaxel resistance in prostate cancer,"LIBERMANN, TOWIA",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$160,515"
Prostate Cancer,2016,NCI,5R01CA187273-02,,Suppression of Prostate Tumor Growth and Metastasis by Inhibition of Vimentin,"RANGNEKAR, VIVEK",UNIVERSITY OF KENTUCKY,KY,"$344,269"
Prostate Cancer,2016,NIGMS,4R01GM106020-04,,Heterodimerization of CXCR4 and CB2 Inhibits Prostate Cancer Cell Movement,"HINTON, CIMONA",CLARK ATLANTA UNIVERSITY,GA,"$294,500"
Prostate Cancer,2016,NCI,4R01CA169363-04,,Modulation of antitumor immunity by dietary soy and its isoflavone constituents,"LESINSKI, GREGORY",OHIO STATE UNIVERSITY,OH,"$319,550"
Prostate Cancer,2016,NCI,5R01CA199668-02,,Stimuli-responsive crosslinked theranostics against advanced prostate cancer,"LI, YUANPEI",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$359,138"
Prostate Cancer,2016,NCI,4R01CA167041-05,,High Density Lipoprotein Nanoparticles for siRNA Delivery,"THAXTON, COLBY",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,588"
Prostate Cancer,2016,NCI,4R01CA108646-11,,TGF Beta Signals in Prostate Stromal-Epithelial Interactions,"BHOWMICK, NEIL",CEDARS-SINAI MEDICAL CENTER,CA,"$292,148"
Prostate Cancer,2016,NCI,4R01CA130536-22,,Mechanisms of Radioresistance and Cell Cycle Progression,"LIEBERMAN, HOWARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$347,814"
Prostate Cancer,2016,NCATS,5R43TR001283-02,,Development and Validation of a Novel Biomarker Assay for Cancer Diagnostics,"SELANDER, KATRI","BLONDIN BIOSCIENCE, LLC",AL,"$374,500"
Prostate Cancer,2016,NCI,1R01CA204430-01,,Mitochondria in Prostate Cancer Diversity,"SINGH, KESHAV",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$336,263"
Prostate Cancer,2016,NCI,1R01CA205400-01,,Distinct Redox Mechanism in Normal and Cancer Cells as a Novel Therapeutic Target,"ST CLAIR, DARET",UNIVERSITY OF KENTUCKY,KY,"$351,697"
Prostate Cancer,2016,NCI,5R21CA174537-03,,Immobilized protease activity tests for developing functional cancer biomarkers.,"TEMPST, PAUL",SLOAN-KETTERING INST CAN RESEARCH,NY,"$229,550"
Prostate Cancer,2016,NIGMS,4SC1CA182844-04,,Titanium-gold-based chemotherapeutics for prostate and kidney cancer,"CONTEL, MARIA",BROOKLYN COLLEGE,NY,"$353,250"
Prostate Cancer,2016,NCI,5R01CA137050-07,,Mechanism and treatment of PTEN mutant prostate tumorigenesis,"TROTMAN, LLOYD",COLD SPRING HARBOR LABORATORY,NY,"$398,400"
Prostate Cancer,2016,NCI,5R01CA178610-03,,The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer,"ALUMKAL, JOSHI",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$316,934"
Prostate Cancer,2016,NCI,5R01CA199741-02,,CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer,"CRAMER, SCOTT",UNIVERSITY OF COLORADO DENVER,CO,"$388,676"
Prostate Cancer,2016,NCI,5U01CA194730-02,,MicroRNAs in African American Prostate Cancer,"KUMAR, DEEPAK",UNIVERSITY OF THE DISTRICT OF COLUMBIA,DC,"$308,544"
Prostate Cancer,2016,NIBIB,1R03EB022141-01,,Towards an Effective Prostate Cancer-Targeting Biomaterial,"CONDA SHERIDAN, MARTIN",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$75,250"
Prostate Cancer,2016,NCI,1R21CA199171-01A1,,Genetic Signatures Underlying Prostate Cancer Metastasis in AfricanAmericans,"FARUQUE, MEZBAH",HOWARD UNIVERSITY,DC,"$229,898"
Prostate Cancer,2016,NCI,1R01CA204786-01,,Modulation of host intrinsic immunity to reduce prostate cancer disparity,"KARAN, DEV",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,"$313,306"
Prostate Cancer,2016,NCI,5R21CA194750-02,,The role of exRNA in  Health Disparity of Prostate Cancer,"ABD ELMAGEED, ZAKARIA",TULANE UNIVERSITY OF LOUISIANA,LA,"$162,426"
Prostate Cancer,2016,NCI,5R21CA190921-02,,Natural Agent in Prevention of Prostate Cancer,"SHUKLA, SANJEEV",CASE WESTERN RESERVE UNIVERSITY,OH,"$206,843"
Prostate Cancer,2016,NIBIB,5R21EB020946-02,,"Detection of lethal prostate cancer with macromolecule-based, EGFL-7 targeted MR imaging approach","STEINMETZ, NICOLE",CASE WESTERN RESERVE UNIVERSITY,OH,"$230,295"
Prostate Cancer,2016,NCCIH,5R01AT007395-06,,Mechanisms of prostate cancer prevention by Korean Angelica,"LU, JUNXUAN",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$431,056"
Prostate Cancer,2016,NCI,5U01CA168925-05,,Carbohydrate Antigenic Biomarkers for Epithelial Cancers,"GREENE, MARK",UNIVERSITY OF PENNSYLVANIA,PA,"$444,838"
Prostate Cancer,2016,NIBIB,1R01EB022134-01,,"Image-guided, Transcatheter Peptide Receptor Radio Therapy for Prostate Cancer","TWEEDLE, MICHAEL",OHIO STATE UNIVERSITY,OH,"$581,935"
Prostate Cancer,2016,NCI,1R21CA194798-01A1,,Exploring high-does testosterone as a potential treatment for abiraterone-resistant prostate cancer,"COREY, EVA",UNIVERSITY OF WASHINGTON,WA,"$168,019"
Prostate Cancer,2016,NCI,4R01CA168917-05,,Hybrid nanotechnology to target metastatic advanced prostate cancer,"WONG, HO-LUN",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$317,475"
Prostate Cancer,2016,NCI,4R01CA155268-05,,Development of an Optimal MRI Platform for Prostate Investigations at 7 Tesla,"METZGER, GREGORY",UNIVERSITY OF MINNESOTA,MN,"$237,582"
Prostate Cancer,2016,NCI,1R21CA197887-01A1,,Autophagy regulation of prostate tumor development,"THORBURN, ANDREW",UNIVERSITY OF COLORADO DENVER,CO,"$202,928"
Prostate Cancer,2016,NCI,4R01CA172495-04,,Targeting myristoylation of Src family kinases for inhibition of prostate tumorig,"CAI, HOUJIAN",UNIVERSITY OF GEORGIA,GA,"$311,250"
Prostate Cancer,2016,NCI,4UM1CA167552-05,,Cancer Epidemiology Cohort in Male Health Professionals,"WILLETT, WALTER",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$2,313,689"
Prostate Cancer,2016,NCI,1R21CA205108-01,,A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer,"MOHLER, JAMES",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$162,075"
Prostate Cancer,2016,NCI,4R01CA178846-04,,MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES,"SLINGLUFF, CRAIG",UNIVERSITY OF VIRGINIA,VA,"$394,792"
Prostate Cancer,2016,NCI,4R01CA164331-05,,Identification of Inhibitors of the N-Terminal Region of the Androgen Receptor,"RETTIG, MATTHEW",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$261,450"
Prostate Cancer,2016,NCI,5R01CA191234-02,,Radiotherapy-induced tumor immunity,"SCHAUE, DORTHE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$352,275"
Prostate Cancer,2016,NCI,1R21CA196570-01A1,,Reprogramming of Prostate Stromal Cells by Prostate Inflammation,"XIN, LI",BAYLOR COLLEGE OF MEDICINE,TX,"$222,296"
Prostate Cancer,2016,NCI,1R21CA205257-01,,The Role of Mitochondrial Heterogeneity in Pyruvate Flux in Prostate Cancer Progression,"MCGUIRE, SEAN",BAYLOR COLLEGE OF MEDICINE,TX,"$206,843"
Prostate Cancer,2016,NCI,4P01CA134294-09,7461,Methods for Comparative Effectiveness Research in Cancer,"HERNAN, MIGUEL",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$220,122"
Prostate Cancer,2016,NCI,5K08CA187417-03,,Genomic instability and DNA repair in a distinct molecular class of prostate canc,"BARBIERI, CHRISTOPHER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$172,908"
Prostate Cancer,2016,NIEHS,5R01ES011126-13,,A NESTED CASE-CONTROL STUDY OF PROSTATE CARCINOGENESIS,"RYBICKI, BENJAMIN",HENRY FORD HEALTH SYSTEM,MI,"$481,890"
Prostate Cancer,2016,NCI,1R15CA206067-01,,"AIF-mediated Control of Mitochondrial Biogenesis, Metabolism, and Cellular Redox Balance","WILKINSON, JOHN",NORTH DAKOTA STATE UNIVERSITY,ND,"$435,000"
Prostate Cancer,2016,NCI,4P01CA163227-04,6435,Epigenetic Reprogramming of AR Function in CRPC,"BROWN, MYLES",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$338,022"
Prostate Cancer,2016,NCI,4P01CA163227-04,6436,Administrative/Clinical/Biostatistics Core,"BALK, STEVEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$137,547"
Prostate Cancer,2016,NCI,4P01CA163227-04,6437,Facility Biospecimen and Xenograft Core,"VESSELLA, ROBERT",UNIVERSITY OF WASHINGTON,WA,"$296,578"
Prostate Cancer,2016,NCI,4P01CA163227-04,6438,Steroid Analytical Core,"PENNING, TREVOR",UNIVERSITY OF PENNSYLVANIA,PA,"$278,480"
Prostate Cancer,2016,NCI,5R21CA193080-02,,TIMP3: A Molecular Target of Green Tea Polyphenols,"GUPTA, SANJAY",CASE WESTERN RESERVE UNIVERSITY,OH,"$206,843"
Prostate Cancer,2016,NIGMS,7P20GM103639-05,7852,TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo),"WOO, SUKYUNG",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$204,739"
Prostate Cancer,2016,NCI,1R21CA205627-01,,Novel Mouse Models to define Genetic Drivers of Aggressive Prostate Cancer,"ELLIS, LEIGH",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$223,808"
Prostate Cancer,2016,NCI,1R21CA198820-01A1,,Functions of histone variants in castration-resistance prostate cancer,"ISHOV, ALEXANDER",UNIVERSITY OF FLORIDA,FL,"$195,750"
Prostate Cancer,2016,NCI,5R21CA198643-02,,Developing small-molecule probes for protein arginine methyltransferases,"WANG, QIU",DUKE UNIVERSITY,NC,"$166,329"
Prostate Cancer,2016,NCI,5R01CA134514-08,,Role of FOXO1 Inactivation in Prostate Tumorigenesis,"HUANG, HAOJIE",MAYO CLINIC ROCHESTER,MN,"$357,750"
Prostate Cancer,2016,NCI,4R01CA166655-05,,Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy,"KURHANEWICZ, JOHN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$620,489"
Prostate Cancer,2016,NCI,5R01CA183962-02,,Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care,"HERNANDEZ-BOUSSARD, TINA",STANFORD UNIVERSITY,CA,"$593,747"
Prostate Cancer,2016,NIGMS,5R01GM027681-36,,Programmable DNA Binding Oligomers for Control of Transcription,"DERVAN, PETER",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$408,538"
Prostate Cancer,2016,NIBIB,5R01EB019288-03,,Polymeric nanoparticles with imaging capability for therapeutic peptide delivery,"PEREZ, J",CEDARS-SINAI MEDICAL CENTER,CA,"$292,627"
Prostate Cancer,2016,NCI,5P30CA013696-42,6104,Prostate Cancer Program,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$35,133"
Prostate Cancer,2016,NCI,5R01CA196270-02,,Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer,"CHAKRAVARTI, DEBABRATA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$441,943"
Prostate Cancer,2016,NCI,5R21CA184685-02,,Novel gene that determines metastatic phenotype in African-American men with PCa,"BHAT, MOHAMMAD SALEEM",UNIVERSITY OF MINNESOTA,MN,"$173,232"
Prostate Cancer,2016,NCI,5U01CA184966-02,,Genetic factors for race related prostate cancer.,"DAHIYA, RAJVIR",NORTHERN CALIFORNIA INSTITUTE/RES/EDU,CA,"$318,098"
Prostate Cancer,2016,NCI,5R01CA182569-02,,USP22 Function in Advanced Prostate Cancer,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$457,244"
Prostate Cancer,2016,NCI,4R01CA169188-05,,Molecular Imaging with FACBC PET-CT to Improve Post prostatectomy Radiotherapy,"JANI, ASHESH",EMORY UNIVERSITY,GA,"$400,052"
Prostate Cancer,2016,NCI,5R21CA191740-02,,Camptothecin Transformative Nanotubes as Effective Drug Carriers,"CUI, HONGGANG",JOHNS HOPKINS UNIVERSITY,MD,"$170,845"
Prostate Cancer,2016,NIBIB,5R01EB020426-03,,SCH: Proactive Health Monitoring Using Individualized Analysis of Tissue Elastic*,"LIN, MING",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$214,615"
Prostate Cancer,2016,NCI,1R01CA197477-01A1,,Hypoxia: Impact on Src Signaling and Prostate Cancer,"SIEMANN, DIETMAR",UNIVERSITY OF FLORIDA,FL,"$356,553"
Prostate Cancer,2016,NCI,1R01CA196835-01A1,,Treatment of Castration-resistant Prostate Cancer (CRPC),"LIU, XIAOQI",PURDUE UNIVERSITY,IN,"$354,563"
Prostate Cancer,2016,NCI,1R01CA197996-01A1,,Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.,"SMIRAGLIA, DOMINIC",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$389,422"
Prostate Cancer,2016,NCI,1R01CA196931-01A1,,The Genetic Basis of Aggressive Prostate Cancer: The Role of Rare Variation,"HAIMAN, CHRISTOPHER",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$610,682"
Prostate Cancer,2016,NCI,5F30CA200411-03,,Optimization of Non-Ablative Focused Ultrasound Therapy for Tumor Immunity,"SKALINA, KARIN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$48,576"
Prostate Cancer,2016,NCI,5R01CA131945-08,,Molecular Link Between Metabolic Syndrome and Prostate Cancer,"LODA, MASSIMO",DANA-FARBER CANCER INST,MA,"$377,253"
Prostate Cancer,2016,NCI,1R01CA198097-01A1,,Co-targeting oncogenic pathways in advanced prostate cancer,"CICHOWSKI, KAREN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$381,212"
Prostate Cancer,2016,NCI,1R01CA197944-01A1,,Development of cancer therapeutic TBK1/IKKi dual inhibitors,"LUO, JUN-LI",SCRIPPS FLORIDA,FL,"$439,200"
Prostate Cancer,2016,NCI,5R01CA190378-02,,The Notch Signaling in Prostate Homeostasis and Carcinogenesis,"XIN, LI",BAYLOR COLLEGE OF MEDICINE,TX,"$362,569"
Prostate Cancer,2016,NCI,5R21CA191725-02,,4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci,"FREEDMAN, MATTHEW",DANA-FARBER CANCER INST,MA,"$185,077"
Prostate Cancer,2016,NCI,5R01CA197160-02,,Neuroendocrine mechanisms of prostate cancer progression,"NIKITIN, ALEXANDER",CORNELL UNIVERSITY,NY,"$348,145"
Prostate Cancer,2016,NIAAA,5R21AA024330-02,,"Fetal alcohol, estrogen-regulated genes and prostate cancer","SARKAR, DIPAK","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$184,063"
Prostate Cancer,2016,NCI,5R21CA191757-02,,Modeling human prostate cancer by cellular reprogramming,"SHEN, MICHAEL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$208,800"
Prostate Cancer,2016,NIBIB,4R01EB017449-04,,Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods,"VIGNERON, DANIEL","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$1,185,393"
Prostate Cancer,2016,NCI,4P30CA043703-26,5473,TISSUE RESOURCES CORE FACILITY,"GERSON, STANTON",CASE WESTERN RESERVE UNIVERSITY,OH,"$151,500"
Prostate Cancer,2016,NCI,4P30CA016087-36,6482,GENITOURINARY CANCERS,"CARROLL, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$26,139"
Prostate Cancer,2016,NCI,1K23CA197526-01A1,,Overcoming drug resistance in metastatic castration resistant prostate cancer with a novel combination of TGF-beta inhibition and enzalutamide,"PALLER, CHANNING",JOHNS HOPKINS UNIVERSITY,MD,"$177,120"
Prostate Cancer,2016,NCI,5R01CA173200-05,,Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors,"KRAFT, ANDREW",UNIVERSITY OF ARIZONA,AZ,"$318,513"
Prostate Cancer,2016,NCI,5U01CA183031-02,,PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$394,519"
Prostate Cancer,2016,NCI,1K99CA197804-01A1,,Epigenetic Mechanisms Controlling T-cell Exhaustion in Prostate Cancer,"KISSICK, HAYDN",EMORY UNIVERSITY,GA,"$111,730"
Prostate Cancer,2016,NCI,1K99CA194289-01A1,,MDSC-tumor crosstalk in prostate cancer progression and castration resistance,"WANG, GUOCAN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$104,445"
Prostate Cancer,2016,NCI,4P50CA090381-14,5015,Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance,"MUCCI, LORELEI",DANA-FARBER CANCER INST,MA,"$336,247"
Prostate Cancer,2016,NCI,4P50CA090381-14,5016,Gleason-based mRNA and Metabolomic Profiling to Predict Prostate Cancer Progress,"LODA, MASSIMO",DANA-FARBER CANCER INST,MA,"$243,036"
Prostate Cancer,2016,NCI,4P50CA090381-14,5017,Genomic Determinants of Resistance to Primary Androgen Deprivation Therapy and A,"GARRAWAY, LEVI",DANA-FARBER CANCER INST,MA,"$241,043"
Prostate Cancer,2016,NCI,4P50CA090381-14,5018,Targeting Mechanisms Driveing AR Activity in Advanced CRPC,"BALK, STEVEN",DANA-FARBER CANCER INST,MA,"$308,708"
Prostate Cancer,2016,NCI,4P50CA090381-14,5019,Administrative Core,"KANTOFF, PHILIP",DANA-FARBER CANCER INST,MA,"$260,573"
Prostate Cancer,2016,NCI,4P50CA090381-14,5020,Biostatistics and Computational Biology Core,"REGAN, MEREDITH",DANA-FARBER CANCER INST,MA,"$189,154"
Prostate Cancer,2016,NCI,4P50CA090381-14,5021,Tissue and Pathology Core,"LODA, MASSIMO",DANA-FARBER CANCER INST,MA,"$240,833"
Prostate Cancer,2016,NCI,4P50CA090381-14,5022,Developmental Research Program,"KANTOFF, PHILIP",DANA-FARBER CANCER INST,MA,"$171,204"
Prostate Cancer,2016,NCI,4P50CA090381-14,5023,Career Development Program,"KANTOFF, PHILIP",DANA-FARBER CANCER INST,MA,"$171,202"
Prostate Cancer,2016,NCI,4K24CA121990-10,,Midcareer Investigator Award,"SMITH, MATTHEW",MASSACHUSETTS GENERAL HOSPITAL,MA,"$185,972"
Prostate Cancer,2016,NCI,5R21CA199628-03,,Exosomes Promote Disease Aggressiveness in African American Prostate Cancer,"DEEP, GAGAN",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$168,563"
Prostate Cancer,2016,NCI,5R01CA199663-02,,Image-guided radiation-induced permeability (IGRIP) for IGDD,"KRON, STEPHEN",UNIVERSITY OF CHICAGO,IL,"$495,216"
Prostate Cancer,2016,NCI,5R01CA179115-03,,"Dynamic, multi-cohort prediction modeling of prostate biopsy outcome","VICKERS, ANDREW",SLOAN-KETTERING INST CAN RESEARCH,NY,"$442,771"
Prostate Cancer,2016,NCI,4R01CA165862-05,,Genome-wide sequencing of prostate cancer in men of African ancestry,"HAIMAN, CHRISTOPHER",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$657,327"
Prostate Cancer,2016,NIGMS,5SC2CA200520-02,,Novel Hyperpolarized Agents for Metabolic Imaging of Cancer,"BILLINGSLEY, KELVIN",SAN FRANCISCO STATE UNIVERSITY,CA,"$154,000"
Prostate Cancer,2016,NIGMS,5R01GM112524-04,,Regulation of the Class IA PI 3-kinase PIK3CB,"BACKER, JONATHAN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$404,897"
Prostate Cancer,2016,NCI,1R01CA206189-01,,Nanoparticle-mediated treatment for bone metastasis,"LABHASETWAR, VINOD",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$312,562"
Prostate Cancer,2016,NCI,5F32CA192630-02,,AR variant regulation during EMT and disease progression,"WARE, KATHRYN",DUKE UNIVERSITY,NC,"$58,002"
Prostate Cancer,2016,NCI,5K99CA197315-03,,Nuclear Factor I/B Action in Castrate Resistant Prostate Cancer,"GRABOWSKA, MAGDALENA",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$92,532"
Prostate Cancer,2016,NCI,5R01CA190713-03,,cis-splicing of adjacent genes in prostate cancer,"LI, HUI",UNIVERSITY OF VIRGINIA,VA,"$327,850"
Prostate Cancer,2016,NCI,4R01CA171315-05,,Internalizing human antibody-targeted nanosized siRNA therapeutics,"LIU, BIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$328,888"
Prostate Cancer,2016,NIBIB,4K01EB015745-05,,Blood-based biomarker amplification using high intensity focused ultrasound (HIFU,"KHOKHLOVA, TATIANA",UNIVERSITY OF WASHINGTON,WA,"$144,456"
Prostate Cancer,2016,NCI,1F30CA210912-01A1,,Cell-Mediated Immunity Following Listeria monocytogenes Induced Inflammasome Activation,"THEISEN, ERIN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$31,690"
Prostate Cancer,2016,NCI,4R01CA157881-07,,Genetic determinants of gene expression phenotypes in aggressive prostate cancer,"WANG, LIANG",MEDICAL COLLEGE OF WISCONSIN,WI,"$550,809"
Prostate Cancer,2016,NCI,4R01CA182670-04,,Developing targeted therapy with prostate cancer specific nanomedicine,"HSIEH, JER-TSONG",UT SOUTHWESTERN MEDICAL CENTER,TX,"$315,210"
Prostate Cancer,2016,NCI,4U01CA167234-05,,METABOLOMIC PROFILING AND BIOLOGIC BASIS OF RACIAL DISPARITY IN PROSTATE CANCER,"SREEKUMAR, ARUN",BAYLOR COLLEGE OF MEDICINE,TX,"$324,183"
Prostate Cancer,2016,NCI,5R01CA187342-03,,Role of extracellular Hsp90 in epithelial cell polarity and invasion,"ISAACS, JENNIFER",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$310,213"
Prostate Cancer,2016,NCI,5R01CA190105-03,,(PQC4) Habitats in Prostate Cancer,"GILLIES, ROBERT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$682,812"
Prostate Cancer,2016,NIGMS,5SC1CA193758-03,,Targeted Nanotherapy for prostate cancer,"SINGH, RAJESH",MOREHOUSE SCHOOL OF MEDICINE,GA,"$353,750"
Prostate Cancer,2016,NCI,5R01CA182503-03,,Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer,"CARVER, BRETT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$439,351"
Prostate Cancer,2016,NCI,5F31CA189764-03,,Regulation of prostate cancer progression by ALCAM proteolysis,"HEBRON, KATIE",VANDERBILT UNIVERSITY,TN,"$21,750"
Prostate Cancer,2016,NCI,1R01CA206222-01,,Targeting key orphan nuclear receptor in lethal prostate cancer,"CHEN, HONGWU",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$358,756"
Prostate Cancer,2016,NCI,4R01CA165574-05,,Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer,"SIMPSON, MELANIE",UNIVERSITY OF NEBRASKA LINCOLN,NE,"$301,058"
Prostate Cancer,2016,NCI,4UM1CA182883-04,,PCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research,"TANGEN, CATHERINE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$992,344"
Prostate Cancer,2016,NCI,5R33CA183688-02,,RASL-Seq Expression Profiling of FFPE Tissues,"YEAKLEY, JOANNE","BIOSPYDER TECHNOLOGIES, INC.",CA,"$325,428"
Prostate Cancer,2016,NCI,5R01CA172436-03,,Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial,"GOLDKORN, AMIR",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$669,388"
Prostate Cancer,2016,NCI,5R01CA166440-03,,Towards selective androgen deprivation by targeting androgen activation of SRF,"HEEMERS, HANNELORE",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$329,794"
Prostate Cancer,2016,NCI,5R01CA184712-03,,Precision Medicine Approach to Prostate Cancer Active Surveillance,"RUBIN, MARK",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$695,027"
Prostate Cancer,2016,NCI,5R01CA189295-03,,MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis,"POLLACK, ALAN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$596,203"
Prostate Cancer,2016,NCI,5R33CA196457-02,,Improving biospecimen quality by verifying adequacy at the point-of-acquisition with ex vivo structured illumination microscopy,"BROWN, JONATHAN",TULANE UNIVERSITY OF LOUISIANA,LA,"$302,416"
Prostate Cancer,2016,NCI,5K08CA188615-03,,Resistance to Emerging Androgen Deprivation Therapies in Prostate Cancer,"VAN ALLEN, ELIEZER",DANA-FARBER CANCER INST,MA,"$177,120"
Prostate Cancer,2016,NCI,4K07CA163616-05,,Effectiveness of Radiotherapy for Prostate Cancer,"BEKELMAN, JUSTIN",UNIVERSITY OF PENNSYLVANIA,PA,"$174,960"
Prostate Cancer,2016,RMAP,4UH3TR000928-04,,Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni,"ABDEL-MAGEED, ASIM",TULANE UNIVERSITY OF LOUISIANA,LA,"$999,920"
Prostate Cancer,2016,NCCIH,4R01AT007065-05,,Curcuma Longa: epigenetic effects in prostate and colon cancer,"KONG, AH-NG","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$371,811"
Prostate Cancer,2016,OD,4R01AT007065-05,,Curcuma Longa: epigenetic effects in prostate and colon cancer,"KONG, AH-NG","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$92,000"
Prostate Cancer,2016,NCI,4K01CA169041-05,,Financial well-being following prostate cancer diagnosis,"TUCKER-SEELEY, REGINALD",DANA-FARBER CANCER INST,MA,"$135,029"
Prostate Cancer,2016,NCI,5R01CA188609-03,,An inevitable mechanism of resistance to androgen-directed therapy,"DONG, YAN",TULANE UNIVERSITY OF LOUISIANA,LA,"$312,288"
Prostate Cancer,2016,RMAP,4U19CA179512-04,7165,Regulated Release and Paracrine Function of Ex-microRNAs in Prostate Cancer,"BLELLOCH, ROBERT","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$136,012"
Prostate Cancer,2016,NCI,5K07CA190541-02,,Repurposing Metformin and Aspirin for Prostate Cancer Prevention and Control,"TAN, XIANGLIN",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$170,541"
Prostate Cancer,2016,NCI,1F32CA206277-01,,Innate Metabolic MRI of Macrophage Infiltration in Prostate Cancer,"LEFTIN, AVIGDOR",SLOAN-KETTERING INST CAN RESEARCH,NY,"$62,010"
Prostate Cancer,2016,NCI,4K01CA168934-05,,Targeting Lipid Oxidation for Prostate Cancer Imaging and Therapy,"SCHLAEPFER, ISABEL",UNIVERSITY OF COLORADO DENVER,CO,"$122,958"
Prostate Cancer,2016,NCI,4K01CA172478-04,,Brachytherapy in situ dose-painting administered via gold-nanoparticle eluters,"NGWA, WILFRED",DANA-FARBER CANCER INST,MA,"$176,769"
Prostate Cancer,2016,NINR,5K01NR015246-02,,Mitochondrial Bioenergetic Mechanism of Cancer Related Fatigue,"HSIAO, CHAO-PIN",CASE WESTERN RESERVE UNIVERSITY,OH,"$90,990"
Prostate Cancer,2016,NCI,1F32CA206394-01,,Targeting SDF1/CXCR4 signaling to mobilize and kill circulating and disseminated prostate tumor cells,"VALKENBURG, KENNETH",JOHNS HOPKINS UNIVERSITY,MD,"$54,294"
Prostate Cancer,2016,NCI,4R01CA183570-04,,PROMISS - Prostate Modeling to Identify Surveillance Strategies,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$567,040"
Prostate Cancer,2016,NCI,4R01CA172382-05,,Elucidating a novel molecular biomarker for castration-resistant prostate cancer,"SHARIFI, NIMA",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$322,844"
Prostate Cancer,2016,NCI,5P20CA192973-03,5195,Pilot Project #2,"PONNAZHAGAN, SELVARANGAN",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$44,761"
Prostate Cancer,2016,NCI,5R01CA178888-03,,MnTE-2-PyP as a radioprotector in prostate cancer therapy,"OBERLEY-DEEGAN, REBECCA",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$314,612"
Prostate Cancer,2016,NCI,1U13CA206383-01,,"2016 AUA Urologic Oncology Research Symposium: ""Forging New Paths in Research to Advance Urologic Oncology","BEST, CAROLYN",AMERICAN UROLOGICAL ASSOCIATION,MD,"$10,000"
Prostate Cancer,2016,NCI,4U54CA096300-14,6960,Full Project A: Multivariate Prediction of Prostate Cancer in Puerto Rican and,"PETTAWAY, CURTIS",UNIVERSITY OF PUERTO RICO,PR,"$77,742"
Prostate Cancer,2016,NCI,1F31CA200390-01A1,,The Ron Receptor in Castration Resistant Prostate Cancer,"BROWN, NICHOLAS",UNIVERSITY OF CINCINNATI,OH,"$31,806"
Prostate Cancer,2016,NCI,2R01CA123362-05A1,,PDGF D and Prostate Cancer Bone Metastasis,"KIM, HYEONG-REH",WAYNE STATE UNIVERSITY,MI,"$351,673"
Prostate Cancer,2016,NCI,5P20CA192976-03,5182,Project 2: 2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership,"MISHRA, MANOJ",ALABAMA STATE UNIVERSITY,AL,"$44,672"
Prostate Cancer,2016,NCI,5R01CA200064-02,,Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology,"BACKMAN, VADIM",NORTHWESTERN UNIVERSITY,IL,"$621,871"
Prostate Cancer,2016,NCI,5R01CA189623-03,,"Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.","GEORGIOU, GEORGE","UNIVERSITY OF TEXAS, AUSTIN",TX,"$580,448"
Prostate Cancer,2016,NCI,1R01CA197516-01A1,,3D Prostate Histochemometry to Predict Disease Recurrence,"BHARGAVA, ROHIT",UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,IL,"$405,047"
Prostate Cancer,2016,NCI,5U01CA198900-02,,Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling,"TSENG, HSIAN-RONG",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$471,503"
Prostate Cancer,2016,NCI,5P50CA180995-02,7210,Biostatistics and Bioinformatics Core,"JOVANOVIC, BORKO",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$215,910"
Prostate Cancer,2016,NCI,5P50CA180995-02,7211,Biospecimen Pathology Core,"KAUL, KAREN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$249,385"
Prostate Cancer,2016,NCI,5P50CA180995-02,7212,"Administrative, Leadership Development and Advocacy Core","CATALONA, WILLIAM",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$188,009"
Prostate Cancer,2016,NCI,5P50CA180995-02,7213,Impact of Germline Genetic Variants and Failure of Active Surveillance for Prostate Cancer,"CATALONA, WILLIAM",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$228,027"
Prostate Cancer,2016,NCI,5P50CA180995-02,7214,Glucocorticoid Receptor Transcriptional Activity and the Evolution of Enzalutamide-Resistant CRPC,"SZMULEWITZ, RUSSELL",UNIVERSITY OF CHICAGO,IL,"$433,908"
Prostate Cancer,2016,NCI,5P50CA180995-02,7215,EPHB4 Receptor Kinase as a Target in Prostate Cancer,"ABDULKADIR, SARKI",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$285,799"
Prostate Cancer,2016,NCI,5P50CA180995-02,7216,Targeting FOXA1-downstream pathways: a novel therapeutic strategy for castration-resistant prostate cancer,"YU, JINDAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$261,640"
Prostate Cancer,2016,NCI,5P50CA180995-02,7217,Developmental Research Program,"CATALONA, WILLIAM",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$213,943"
Prostate Cancer,2016,NCI,5P50CA180995-02,7218,Career Development Program,"BERGAN, RAYMOND",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$81,919"
Prostate Cancer,2016,NCI,1R01CA206488-01,,"HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers","NIXON, DOUGLAS",GEORGE WASHINGTON UNIVERSITY,DC,"$531,650"
Prostate Cancer,2016,NCI,4K07CA178258-04,,Optimal Strategy for Conservative Management of Prostate Cancer,"LOEB, STACY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$178,097"
Prostate Cancer,2016,NCI,5R44CA199905-02,,Multi-Modality MRI/CT Markers for Improved Assessment of Prostate Cancer,"BRIGHT, ANDREW","C4 IMAGING, LLC",PA,"$640,660"
Prostate Cancer,2016,NIGMS,5SC1CA187494-03,,"Emotion-Regulation, Inflammatory Processes, and Depression in Prostate Cancer Sur","HOYT, MICHAEL",HUNTER COLLEGE,NY,"$390,000"
Prostate Cancer,2016,NCI,4P30CA082103-18,6390,Prostate Cancer,"MCCORMICK, FRANK","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,$163
Prostate Cancer,2016,NCI,5R21CA184605-02,,A Randomized Clinical Trial of Exercise for Men with Metastatic Prostate Cancer,"KENFIELD, STACEY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$206,843"
Prostate Cancer,2016,NCI,5R01CA197910-02,,Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells,"MULHOLLAND, DAVID",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$387,731"
Prostate Cancer,2016,NCI,5R01CA122320-09,,Chemical markers of heterocyclic aromatic amines for human biomonitoring,"TURESKY, ROBERT",UNIVERSITY OF MINNESOTA,MN,"$574,804"
Prostate Cancer,2016,NCI,4P50CA092131-14,5079,Career Development Program,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$205,228"
Prostate Cancer,2016,NCI,4P50CA092131-14,5078,Developmental Research Program,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$248,532"
Prostate Cancer,2016,NCI,4P50CA092131-14,5077,Imaging Core,"WU, ANNA",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$179,244"
Prostate Cancer,2016,NCI,4P50CA092131-14,5076,Biostatistics and Bioinformatics Core,"HORVATH, STEVE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$176,467"
Prostate Cancer,2016,NCI,4P50CA092131-14,5075,Pathology Core,"SAID, JONATHAN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$179,244"
Prostate Cancer,2016,NCI,4P50CA092131-14,5074,Administrative Core,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$179,243"
Prostate Cancer,2016,NCI,4P50CA092131-14,5073,Low-Fat/Fish Oil Diet and prostate Cancer Outcomes in Human Cohorts and Mouse Mo,"ARONSON, WILLIAM",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$240,706"
Prostate Cancer,2016,NCI,4P50CA092131-14,5072,Evaluating a Novel Strategy to Target Trop2 in Prostate Cancer,"WITTE, OWEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$247,450"
Prostate Cancer,2016,NCI,4P50CA092131-14,5071,PI3K/AKT and MAPK Pathway Inhibition Therapies in Metastatic and Castration Resi,"WU, HONG",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$247,450"
Prostate Cancer,2016,NCI,4P50CA092131-14,5070,Translating N-Cadherin Targeted Therapy in Castrate Resistant Prostate Cancer,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$253,748"
Prostate Cancer,2016,NCI,5F31CA186660-03,,Elucidating the Molecular Basis of Metastatic Prostate Cancer Cell Progression in,"UPTON, ROSALYND",STANFORD UNIVERSITY,CA,"$43,576"
Prostate Cancer,2016,NCI,5U01CA199338-02,,Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$1,066,817"
Prostate Cancer,2016,NCI,5R01CA182438-03,,Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer,"KIM, HYUNG",CEDARS-SINAI MEDICAL CENTER,CA,"$527,589"
Prostate Cancer,2016,NCI,5R21CA195191-02,,Treating Prostate Cancer with RNAi Prodrugs,"DOWDY, STEVEN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$168,563"
Prostate Cancer,2016,NCI,5F31CA200362-02,,Snail-Cathepsin L Signaling in Human Breast Cancer,"BURTON, LIZA",CLARK ATLANTA UNIVERSITY,GA,"$37,478"
Prostate Cancer,2016,NCI,5P50CA058236-21,5601,PEG-Prom Mediated Theranostics for Prostate Cancer,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$219,786"
Prostate Cancer,2016,NCI,5P50CA058236-21,5602,Tissue-Specific Radiation Sensitization of Prostate Cancer by Aptamer-Targeted siRNA Knock-Down of DNA Repair Pattiway,"LUPOLD, SHAWN",JOHNS HOPKINS UNIVERSITY,MD,"$208,631"
Prostate Cancer,2016,NCI,5P50CA058236-21,5604,Discovery and Pre-Clinical Translation of Rational Epigenetic-Drug/Targeted-Drug Targeted-Drug Combinations,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$233,077"
Prostate Cancer,2016,NCI,5P50CA058236-21,5605,MSC Delivery of PSA Activated Pro-Aerolysin for Prostate Cancer,"ISAACS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$233,916"
Prostate Cancer,2016,NCI,5P50CA058236-21,5606,Developing Telomere Length Variation as a Prognostic Test for Prostate Cancer,"PLATZ, ELIZABETH",JOHNS HOPKINS UNIVERSITY,MD,"$223,405"
Prostate Cancer,2016,NCI,5P50CA058236-21,5607,Administrative Core,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$131,912"
Prostate Cancer,2016,NCI,5P50CA058236-21,5608,Biospecimen/Pathology Core,"EPSTEIN, JONATHAN",JOHNS HOPKINS UNIVERSITY,MD,"$156,023"
Prostate Cancer,2016,NCI,5P50CA058236-21,5609,Biostatistics/Bioinformatics Core,"TROCK, BRUCE",JOHNS HOPKINS UNIVERSITY,MD,"$134,679"
Prostate Cancer,2016,NCI,5P50CA058236-21,5610,Developmental Research Program,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$143,106"
Prostate Cancer,2016,NCI,5P50CA058236-21,5611,Career Development Program,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$143,106"
Prostate Cancer,2016,NCI,5P50CA186786-03,7441,A Precision Medicine Approach to Elucidate Mechanisms of Progression,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN,MI,"$319,824"
Prostate Cancer,2016,NCI,5P50CA186786-03,7442,Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib in Castrate Resistant Prostate Cancer,"KELLER, EVAN",UNIVERSITY OF MICHIGAN,MI,"$246,637"
Prostate Cancer,2016,NCI,5P50CA186786-03,7443,Development of Novel BET Bromodomain Inhibitors for the Treatment of Advanced,"WANG, SHAOMENG",UNIVERSITY OF MICHIGAN,MI,"$257,180"
Prostate Cancer,2016,NCI,5P50CA186786-03,7444,Developing Schlap1 and Other IncRNAs as Prostate Cancer Biomarkers in Urine,"WEI, JOHN",UNIVERSITY OF MICHIGAN,MI,"$235,742"
Prostate Cancer,2016,NCI,5P50CA186786-03,7445,Administration,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN,MI,"$272,831"
Prostate Cancer,2016,NCI,5P50CA186786-03,7446,Biostatistics,"TSODIKOV, ALEXANDER",UNIVERSITY OF MICHIGAN,MI,"$180,878"
Prostate Cancer,2016,NCI,5P50CA186786-03,7447,Tissue/Informatics,"KUNJU, LAKSHMI",UNIVERSITY OF MICHIGAN,MI,"$447,171"
Prostate Cancer,2016,NCI,5P50CA186786-03,7448,Developmental Research Program,"HUSSAIN, MAHA",UNIVERSITY OF MICHIGAN,MI,"$107,594"
Prostate Cancer,2016,NCI,5P50CA186786-03,7449,Career Development Program,"COONEY, KATHLEEN",UNIVERSITY OF MICHIGAN,MI,"$94,142"
Prostate Cancer,2016,NCI,5K01CA188412-03,,PSMAs role in signal transduction pathway switching in prostate cancer,"CAROMILE, LESLIE",UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,CT,"$100,396"
Prostate Cancer,2016,NCI,5U54CA199091-02,6530,Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer,"MIRKIN, CHAD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$657,226"
Prostate Cancer,2016,NCI,4U01CA089600-13,,Prostate Cancer Susceptibility: The ICPCG Study,"THIBODEAU, STEPHEN",MAYO CLINIC ROCHESTER,MN,"$2,291,170"
Prostate Cancer,2016,NCI,4U24CA180918-04,,Quantitative Image Informatics for Cancer Research (QIICR),"KIKINIS, RON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$668,889"
Prostate Cancer,2016,NCI,5R01CA185457-03,,(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment,"FRANGIONI, JOHN","CURADEL, LLC",MA,"$1,005,598"
Prostate Cancer,2016,NINR,5R01NR014502-02,,A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer,"BHASIN, SHALENDAR",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$687,002"
Prostate Cancer,2016,NCI,4P50CA097186-14,7589,Targeting SEMA3C in Castration Resistant Prostate Cancer,"GLEAVE, MARTIN",UNIVERSITY OF BRITISH COLUMBIA,CANADA,"$449,099"
Prostate Cancer,2016,NCI,4P50CA097186-14,7590,Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$229,235"
Prostate Cancer,2016,NCI,4P50CA097186-14,7591,Exploiting Mechanisms of Response and Resistance to Next Generation Androgen Pathway Antagonists,"MOSTAGHEL, ELAHE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$199,440"
Prostate Cancer,2016,NCI,4P50CA097186-14,7592,Leadership and Administration,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$369,253"
Prostate Cancer,2016,NCI,4P50CA097186-14,7594,Biostatistics,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$214,842"
Prostate Cancer,2016,NCI,4P50CA097186-14,7595,Clinical,"YU, EVAN",UNIVERSITY OF WASHINGTON,WA,"$275,842"
Prostate Cancer,2016,NCI,4P50CA097186-14,7596,Developmental Research Program,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$212,144"
Prostate Cancer,2016,NCI,4P50CA097186-14,7597,Career Development Program,"STANFORD, JANET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$212,144"
Prostate Cancer,2016,NCI,5R01CA196259-02,,The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression,"DIGIOVANNI, JOHN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$396,302"
Prostate Cancer,2016,NCI,5U54CA143925-08,6753,Functional Genetic variants as modifiers of prostate cancer progression in Native Americans,"WILDER, JASON",NORTHERN ARIZONA UNIVERSITY,AZ,"$92,811"
Prostate Cancer,2016,NCI,5U54CA143924-08,6762,Functional Genetic variants as modifiers of prostate cancer progression in Native Americans,"WILDER, JASON",UNIVERSITY OF ARIZONA,AZ,"$137,765"
Prostate Cancer,2016,NIGMS,5R01GM114080-02,,Echogenic Polymersomes for Triggered Contents Release,"MALLIK, SANKU",NORTH DAKOTA STATE UNIVERSITY,ND,"$287,625"
Prostate Cancer,2016,NCI,4R01CA161018-04,,Mechanism of PIN development in Abi1/Hssh3bp1 KO mouse,"KOTULA, LESZEK",UPSTATE MEDICAL UNIVERSITY,NY,"$333,870"
Prostate Cancer,2016,NCI,4DP5OD012179-05,,Molecular Imaging of Protein Glycosylation in Living Subjects,"DE LA ZERDA, ADAM",STANFORD UNIVERSITY,CA,"$392,582"
Prostate Cancer,2016,NIDCR,4DP5OD012179-05,,Molecular Imaging of Protein Glycosylation in Living Subjects,"DE LA ZERDA, ADAM",STANFORD UNIVERSITY,CA,$1
Prostate Cancer,2016,NCCIH,5R01AT009152-02,,Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease,"KONG, AH-NG","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$666,025"
Prostate Cancer,2016,NCI,5R01CA151753-06,,An Androgen-Regulated Cytokine Network Controls Prostate Apoptosis.,"KROLEWSKI, JOHN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$333,996"
Prostate Cancer,2016,NCI,4U01CA171146-05,,Basic Cancer Research in Cancer Health Disparities,"GOLDMAN, RADOSLAV",GEORGETOWN UNIVERSITY,DC,"$282,807"
Prostate Cancer,2016,NCI,5K22CA188169-02,,Clonal analysis of epithelial stem cells in prostate regeneration and cancer,"TALOS, FLAMINIA",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$219,866"
Prostate Cancer,2016,NCI,1R43CA206668-01,,A Phase Ib clinical trial with niclosamide plus abiraterone for Castration Resistant Prostate Cancer (CRPC),"LIU, CHENGFEI","PANDOMEDX, INC.",CA,"$299,986"
Prostate Cancer,2016,NCI,4U01CA179701-04,,Role of chemokine receptor in disparities associated with prostate cancer progres,"SINGH, SHAILESH",MOREHOUSE SCHOOL OF MEDICINE,GA,"$124,223"
Prostate Cancer,2016,NCI,5R21CA185276-02,,A new energy restriction mimetic that targets pancreatic cancer,"LANZA-JACOBY, SUSAN",THOMAS JEFFERSON UNIVERSITY,PA,"$169,650"
Prostate Cancer,2016,NIBIB,5R21EB017568-02,,Pilot Human Studies of FMAU PET in Prostate Cancer,"JADVAR, HOSSEIN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$195,850"
Prostate Cancer,2016,NIBIB,1R43EB022464-01,,Patient-specific Disposable Needle Guide: Alternative to In-bore Robotics for MRI-guided transperineal prostate biopsy,"MAGILL, JOHN","HARMONUS, INC.",MA,"$166,588"
Prostate Cancer,2016,NCI,5U01CA184374-02,,Genetics of Prostate Cancer in Africa,"REBBECK, TIMOTHY",DANA-FARBER CANCER INST,MA,"$1,714,675"
Prostate Cancer,2016,NCI,5P20CA192992-03,5263,Project 1 Pilot Research Project,"DAAKA, YEHIA",UNIVERSITY OF FLORIDA,FL,"$49,140"
Prostate Cancer,2016,NCI,5P20CA192992-03,5264,Training and Education Program,"ODEDINA, FOLAKEMI",UNIVERSITY OF FLORIDA,FL,"$23,523"
Prostate Cancer,2016,NCI,1R43CA195910-01A1,,A Novel Treatment of Vasomotor Symptoms in Prostate Cancer Patients,"NGUYEN, VIEN","AGYPHARMA, LLC",TX,"$226,310"
Prostate Cancer,2016,NCI,5F31CA200139-02,,Germline Genetic Pathways for Prostate Cancer Risk and Progression,"TAI, CAROLINE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$35,043"
Prostate Cancer,2016,NCI,5R01CA134675-07,,High-Specificity Imaging Agents for Aggressive Prostate Cancer,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$526,681"
Prostate Cancer,2016,NCI,5R01CA193497-02,,The role of MnSOD allelic variations in prostate cancer etiology and outcome,"DIAMOND, ALAN",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$389,176"
Prostate Cancer,2016,NCI,4R01CA163012-05,,Prostatitis and Prostate Cancer Development,"FONG, LAWRENCE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$414,029"
Prostate Cancer,2016,NCI,5U01CA196390-02,,Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry,"PIENTA, KENNETH",JOHNS HOPKINS UNIVERSITY,MD,"$810,157"
Prostate Cancer,2016,NCI,4R01CA155676-06,,EphA2 kinase in prostate cancer,"WANG, BINGCHENG",CASE WESTERN RESERVE UNIVERSITY,OH,"$256,089"
Prostate Cancer,2016,NCI,5U01CA196387-02,,Stanford Molecular and Cellular Characterization Laboratory,"BROOKS, JAMES",STANFORD UNIVERSITY,CA,"$624,820"
Prostate Cancer,2016,NCI,1R21CA196434-01A1,,Supramolecular matrix materials for prostate cancer cell biology,"VANDER GRIEND, DONALD",UNIVERSITY OF CHICAGO,IL,"$237,000"
Prostate Cancer,2016,NCI,1R01CA196634-01A1,,Improving chemotherapy of castration-resistant prostate cancer,"LIU, XIAOQI",PURDUE UNIVERSITY,IN,"$354,563"
Prostate Cancer,2016,NCI,5K01CA160602-05,,Cryptoprotective Autophagy in Bone Metastatic Prostate Cancer,"DELK, NIKKI",UNIVERSITY OF TEXAS DALLAS,TX,"$115,020"
Prostate Cancer,2016,NCI,5K07CA187546-02,,Risk Prediction for Development of Adverse Effects FOllowing Radiotherapy for Prostate Cancer,"KERNS, SARAH",UNIVERSITY OF ROCHESTER,NY,"$129,867"
Prostate Cancer,2016,NCI,2P50CA092629-16,8652,Core F: Administrative Core,"SCHER, HOWARD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$149,395"
Prostate Cancer,2016,NCI,2P50CA092629-16,8653,Core A: Biospecimen Repository,"REUTER, VICTOR",SLOAN-KETTERING INST CAN RESEARCH,NY,"$229,653"
Prostate Cancer,2016,NCI,2P50CA092629-16,8654,Core B: Biostatistics Core,"HELLER, GLENN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$191,064"
Prostate Cancer,2016,NCI,2P50CA092629-16,8655,Core C: Bioinformatics,"SOCCI, NICHOLAS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$181,418"
Prostate Cancer,2016,NCI,2P50CA092629-16,8656,Core D: Animal Models,"CARVER, BRETT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$162,123"
Prostate Cancer,2016,NCI,2P50CA092629-16,8657,Core E: Organoids Core,"CHEN, YU",SLOAN-KETTERING INST CAN RESEARCH,NY,"$162,122"
Prostate Cancer,2016,NCI,2P50CA092629-16,8658,Development Research Program,"SCHER, HOWARD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$123,536"
Prostate Cancer,2016,NCI,2P50CA092629-16,8659,Career Enhancement Program,"EASTHAM, JAMES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$123,536"
Prostate Cancer,2016,NCI,2P50CA092629-16,8660,Research Project 1: Understanding the Molecular Evolution of Castration-Resistant Prostate Cancer,"TAYLOR, BARRY",SLOAN-KETTERING INST CAN RESEARCH,NY,"$171,770"
Prostate Cancer,2016,NCI,2P50CA092629-16,8661,Research Project 2: Combined inhibition of AR and PI3K signaling in metastatic prostate cancer: Exploiting reciprocal feedback,"ROSEN, NEAL",SLOAN-KETTERING INST CAN RESEARCH,NY,"$171,770"
Prostate Cancer,2016,NCI,2P50CA092629-16,8662,Research Project 3: Heterogeneity in metastatic CRPC and the role of TP53 mutation as a molecular determinant,"SAWYERS, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$215,465"
Prostate Cancer,2016,NCI,2P50CA092629-16,8663,Research Project 4:Investigating and targeting the glucocorticoid receptor (GR) in enzalutamide- and abiraterone-resistant prostate cancer,"SAWYERS, CHARLES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$180,614"
Prostate Cancer,2016,NCI,2P50CA092629-16,8664,Research Project 5: Risk Stratification in Localized Prostate Cancer using Biomarkers in Blood,"LILJA, HANS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$287,533"
Prostate Cancer,2016,NCI,1R21CA206953-01,,Transforming fluorescence lifetime imaging microscopy into a fast and simple platform for high-content molecular analysis,"HAUN, JERED",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$261,386"
Prostate Cancer,2016,NCI,5R00CA178199-04,,Polycomb -Independent Functions of EZH2 in Castration Resistant Prostate Cancer,"XU, KEXIN",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$249,000"
Prostate Cancer,2016,NCI,2P30CA093373-14,8704,Prostate Urothelial Cancer Program,"EVANS, CHRISTOPHER",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$43,902"
Prostate Cancer,2016,NCI,5P01CA098912-12,8454,Core A: Biostatistics and Bioinformatics Core,"TIGHIOUART, MOURAD",CEDARS-SINAI MEDICAL CENTER,CA,"$149,234"
Prostate Cancer,2016,NCI,5P01CA098912-12,8455,Core B: Pathology and High-resolution Imaging Core,"ZAYZAFOON, MAJD",CEDARS-SINAI MEDICAL CENTER,CA,"$195,562"
Prostate Cancer,2016,NCI,5P01CA098912-12,8456,Project 1: Molecular Mechanisms Initiating Prostate Cancer Metastasis,"CHUNG, LELAND",CEDARS-SINAI MEDICAL CENTER,CA,"$311,633"
Prostate Cancer,2016,NCI,5P01CA098912-12,8457,Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis,"FARACH-CARSON, MARY",RICE UNIVERSITY,TX,"$307,895"
Prostate Cancer,2016,NCI,5P01CA098912-12,8458,Project 3: Prostatic Epithelial Stromal Interactions Facilitate Bone Metastasis,"BHOWMICK, NEIL",CEDARS-SINAI MEDICAL CENTER,CA,"$311,328"
Prostate Cancer,2016,NCI,5P01CA098912-12,8459,Project 4: Cholesterol Metabolism and Prostate Cancer Metastasis,"FREEMAN, MICHAEL",CEDARS-SINAI MEDICAL CENTER,CA,"$286,971"
Prostate Cancer,2016,NCI,5P01CA098912-12,8460,Program Integration and Management,"CHUNG, LELAND",CEDARS-SINAI MEDICAL CENTER,CA,"$82,875"
Prostate Cancer,2016,NCI,5U54CA193313-02,7218,Project 1: Modeling tumor evolution in mouse and organoid models,"RABADAN, RAUL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$363,795"
Prostate Cancer,2016,NCI,2P01CA140043-07A1,5160,Core A - Administration and Biostatistics,"ALTIERI, DARIO",WISTAR INSTITUTE,PA,"$212,054"
Prostate Cancer,2016,NCI,2P01CA140043-07A1,5161,Core B - Mass Spectrometry,"SPEICHER, DAVID",WISTAR INSTITUTE,PA,"$212,054"
Prostate Cancer,2016,NCI,2P01CA140043-07A1,5162,Project 1 - Mitochondrial reprogramming in prostate cancer metastasis,"ALTIERI, DARIO",WISTAR INSTITUTE,PA,"$212,054"
Prostate Cancer,2016,NCI,2P01CA140043-07A1,5163,Project 2 - Intercellular communication in prostate cancer,"LANGUINO, LUCIA",THOMAS JEFFERSON UNIVERSITY,PA,"$212,054"
Prostate Cancer,2016,NCI,2P01CA140043-07A1,5164,Project 3 - Mitochondrial regulation of the immunosuppressive prostate cancer microenvironment,"GABRILOVICH, DMITRY",WISTAR INSTITUTE,PA,"$212,054"
Prostate Cancer,2016,NCI,2P01CA140043-07A1,5165,Program Integration and Management,"ALTIERI, DARIO",WISTAR INSTITUTE,PA,"$212,052"
Prostate Cancer,2016,NIBIB,5U01EB012493-07,,Point-of care Microfluidics for Early Detection of Cancer,"TONER, MEHMET",MASSACHUSETTS GENERAL HOSPITAL,MA,"$2,082,080"
Prostate Cancer,2016,NCI,5R01CA193239-02,,Role of RUNX2 in prostate cancer intratumoral androgen synthesis and progression,"HUANG, HAOJIE",MAYO CLINIC ROCHESTER,MN,"$363,713"
Prostate Cancer,2016,NCI,5U54CA199075-02,6376,Multimodality Molecular Nanoimaging of Cancer,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$325,476"
Prostate Cancer,2016,NCI,5R00CA187664-04,,Characterization of Epigenetic Targets in Prostate Cancer,"ASANGANI, IRFAN",UNIVERSITY OF PENNSYLVANIA,PA,"$249,000"
Prostate Cancer,2016,NCI,1R01CA207757-01,,Exploiting RB1 deficiency for the treatment of lethal neuroendocrine prostate cancer,"GOODRICH, DAVID",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$505,760"
Prostate Cancer,2016,NCI,1R01CA207118-01,,Role of histone demethylase JMJD1A in the DNA damage response of prostate cancer cells,"QI, JIANFEI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$352,371"
Prostate Cancer,2016,NCI,1R01CA207311-01,,Role of GATA2 signaling network in Lethal Prostate Cancer,"DOMINGO-DOMENECH, JOSEP",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$478,637"
Prostate Cancer,2016,NCI,1R01CA207749-01,,Impact of Web-Based Lifestyle Interventions on Prostate Cancer Prognosis,"KENFIELD, STACEY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$655,442"
Prostate Cancer,2016,NCI,5U54CA193489-02,7772,Project 2 - Clinical translation,"GATENBY, ROBERT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$356,266"
Prostate Cancer,2016,NCI,1R01CA208254-01,,Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer,"SWEENEY, CHRISTOPHER",DANA-FARBER CANCER INST,MA,"$556,793"
Prostate Cancer,2016,NCI,1R01CA207645-01,,A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use,"WEBER, WOLFGANG",SLOAN-KETTERING INST CAN RESEARCH,NY,"$555,680"
Prostate Cancer,2016,NCI,1R33CA196458-01A1,,Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology,"BHARGAVA, ROHIT",UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,IL,"$387,693"
Prostate Cancer,2016,NCI,5P01CA093900-12,5985,Administrative Core,"KELLER, EVAN",UNIVERSITY OF MICHIGAN,MI,"$338,535"
Prostate Cancer,2016,NCI,5P01CA093900-12,5988,Macrophages induce a tumor-promoting stable EMT in prostate cancer,"PIENTA, KENNETH",JOHNS HOPKINS UNIVERSITY,MD,"$384,035"
Prostate Cancer,2016,NCI,5P01CA093900-12,5989,Regulation of the PCa Metastatic Phenotype by the HSC Niche,"TAICHMAN, RUSSELL",UNIVERSITY OF MICHIGAN,MI,"$313,055"
Prostate Cancer,2016,NCI,5P01CA093900-12,5990,Tumor microvesicle-mediated modulation of the bone microenvironment,"KELLER, EVAN",UNIVERSITY OF MICHIGAN,MI,"$235,093"
Prostate Cancer,2016,NCI,5P01CA093900-12,5991,The role of bone marrow macrophages in skeletal metastasis,"MCCAULEY, LAURIE",UNIVERSITY OF MICHIGAN,MI,"$240,052"
Prostate Cancer,2016,NCI,1K22CA207883-01,,Targeting Ribosomal Biogenesis in Prostate Cancer,"MACIAS, EVERARDO",CEDARS-SINAI MEDICAL CENTER,CA,"$189,681"
Prostate Cancer,2016,NCI,3U01CA196387-01S1,,GENOMICS CLOUD INTEGRATION FOR THE STANFORD MOLECULAR AND CELLULAR CHARACTERIZATION LABORATORY,"BROOKS, JAMES",STANFORD UNIVERSITY,CA,"$63,200"
Prostate Cancer,2016,NCI,1R15CA202775-01A1,,Targeting IKK and HDAC Mediated IL-8 Expression in Ovarian and Prostate Cancer,"VANCUROVA, IVANA",ST. JOHN'S UNIVERSITY,NY,"$495,000"
Prostate Cancer,2016,NCI,1R15CA199019-01A1,,Radiotherapeutic Nanoseeds for Internal Radiation Therapy of Unresectable Solid Tumors,"HAO, YAOWU",UNIVERSITY OF TEXAS ARLINGTON,TX,"$477,039"
Prostate Cancer,2016,NCI,1R01CA200573-01A1,,Characterizing the signaling pathways that regulate Skp2 oncogenic function,"WEI, WENYI",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$395,738"
Prostate Cancer,2016,NCI,1R01CA200660-01A1,,Targeting the MLL complex in Castration Resistant Prostate Cancer,"GREMBECKA, JOLANTA",UNIVERSITY OF MICHIGAN,MI,"$392,750"
Prostate Cancer,2016,NIBIB,1R01EB021362-01A1,,NIR Nerve-specific Fluorescent Imaging for Robotic-assisted Radical Prostatectomy,"GIBBS, SUMMER",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$406,430"
Prostate Cancer,2016,NCI,1R21CA201865-01A1,,Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness,"LIANG, GANGNING",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$215,325"
Prostate Cancer,2016,NCI,1R01CA196662-01A1,,Analysis of drug response in organoids and mouse models,"SHEN, MICHAEL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$597,601"
Prostate Cancer,2016,NCI,1R01CA198145-01A1,,Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment,"COOPERBERG, MATTHEW","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$659,542"
Prostate Cancer,2016,NCI,1R01CA193967-01A1,,The NEDD8 pathway mediated Skp2 degradation in chemoprevention by FKA,"ZI, XIAOLIN",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$353,419"
Prostate Cancer,2016,NCI,1R01CA204924-01A1,,Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy,"BLASBERG, RONALD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$645,363"
Prostate Cancer,2016,NCI,1R01CA201458-01A1,,Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis,"ZHU, LIANG","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$382,013"
Prostate Cancer,2016,NCI,4R44CA192701-02,,NanoCytology to mitigate overdiagnosis of prostate cancer,"SUBRAMANIAN, HARIHARAN","NANOCYTOMICS, LLC",IL,"$713,412"
Prostate Cancer,2016,NCI,1R21CA202417-01A1,,Gene-Gene Interactions and Their Functional Roles in Prostate Cancer Aggressiveness,"LIN, HUI-YI",LSU HEALTH SCIENCES CENTER,LA,"$147,791"
Prostate Cancer,2016,NCI,1R21CA202404-01A1,,MicroRNAs Modulate Therapy Resistance in Prostate Cancer,"NADIMINTY, NAGALAKSHMI",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$170,738"
Prostate Cancer,2016,NCI,1R21CA202199-01A1,,Prostate Specific Membrane Antigen Targeted Photoacoustic Imaging for Prostate Cancer,"CHEN, YING",JOHNS HOPKINS UNIVERSITY,MD,"$227,205"
Prostate Cancer,2016,NCI,1R21CA202122-01A1,,Targeting the glucocorticoid receptor in enzalutamide resistant prostate cancer,"GARABEDIAN, MICHAEL",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$184,331"
Prostate Cancer,2016,NCI,3R01CA184208-02S1,,Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer,"FRIGO, DANIEL",UNIVERSITY OF HOUSTON,TX,"$54,358"
Prostate Cancer,2016,NCI,1R03CA202780-01A1,,"Sources and impact of stigma for rural breast, prostate and lung cancer survivors","THORBURN, SHERYL",OREGON STATE UNIVERSITY,OR,"$73,500"
Prostate Cancer,2016,NCI,4R00CA184397-03,,Proteolytically Cleaved Receptors as Oncogenes and Therapeutic Targets,"STOYANOVA, TANYA",STANFORD UNIVERSITY,CA,"$249,000"
Prostate Cancer,2016,NCI,4R00CA175291-03,,CD117 Signaling as a Mechanism of Prostate Cancer Metastasis,"KERR, BETHANY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$224,101"
Prostate Cancer,2016,NCI,1R01CA206100-01A1,,Automatic Pelvic Organ Delineation in Prostate Cancer Treatment,"SHEN, DINGGANG",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$347,254"
Prostate Cancer,2016,NCI,1F30CA210379-01,,The Role of Centromeres in the Molecular Biology of Prostate Cancer,"SAHA, ANJAN",UNIVERSITY OF MICHIGAN,MI,"$34,716"
Prostate Cancer,2016,NCI,1F30CA210329-01,,Development of a Multimodal Deep Learning Model for the Generation of Cancer Probability Maps and Imaging Biomarkers for Prostate Cancer using Multiparametric MRI,"SARMA, KARTHIK",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$37,074"
Prostate Cancer,2016,NHLBI,1F31HL134231-01,,Opposing Effects of HDL Metabolism on Prostate Cancer,"TRAUGHBER, CYNTHIA",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$36,151"
Prostate Cancer,2016,NCI,1F32CA203402-01A1,,ROLE OF OSTEOCYTE TbetaRII IN PERILACUNAR REMODELING AND BONE METASTASES,"FOWLER, TRISTAN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$58,002"
Prostate Cancer,2016,NIDCR,1F30DE026380-01,,Role of Ferroportin in reducing Prostate Cancer Metastasis,"MANZ, DAVID",UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,CT,"$38,104"
Prostate Cancer,2016,NCI,1F30CA203446-01A1,,Contributions of sympathetic signals to prostate cancer progression.,"ZAHALKA, ALI","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$43,576"
Prostate Cancer,2016,NCI,1R13CA210494-01,,SCIENCE OF GLOBAL PROSTATE CANCER DISPARITIES,"ODEDINA, FOLAKEMI",UNIVERSITY OF FLORIDA,FL,"$25,000"
Prostate Cancer,2016,NCI,1R01CA206456-01A1,,Culturally Adapted Cognitive Behavioral Stress and Self-Management (C-CBSM) Intervention for PC,"PENEDO, FRANK",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$661,905"
Prostate Cancer,2016,NCI,1F31CA210616-01,,Identifying Novel Target Pathways and Therapies in Castration Resistant Prostate Cancer,"SANCHEZ, MARISA",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$31,176"
Prostate Cancer,2016,NCI,2R01CA174294-04,,Multifunctional immunoPET tracers for pancreatic and prostate cancer,"WU, ANNA",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$444,176"
Prostate Cancer,2016,NCI,1R41CA210737-01,,A New Prostate Cancer Treatment to Improve Outcomes and Reduce Side-effects,"FLYNN, RYAN","PXALPHA, LLC",IA,"$225,000"
Prostate Cancer,2016,NCI,1R41CA210772-01,,Developing novel RPPA for the detection of metastatic prostate cancer,"TAO, WEIGUO","TYMORA ANALYTICAL OPERATIONS, LLC",IN,"$225,000"
Prostate Cancer,2016,NCI,2R42CA186414-02,,Intra-procedure Deformable Ultrasound-MRI Fusion for Prostate Biopsies,"PAPADEMETRIS, XENOPHON","ZMK MEDICAL TECHNOLOGIES, D/B/A  EIGEN",CA,"$509,295"
Prostate Cancer,2016,NCI,261200800001E-96-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$1,886,169"
Prostate Cancer,2016,NCI,1UH2CA213392-01,,Impact of aging on prostate cancer with TMPRSS2-ETS gene fusion,"LI, ZHE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$30,000"
Prostate Cancer,2016,NIA,1UH2CA213392-01,,Impact of aging on prostate cancer with TMPRSS2-ETS gene fusion,"LI, ZHE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$30,000"
Prostate Cancer,2016,NCI,3R01CA178431-03S1,,Function of the Stem Cell Transcription Factor Sox2 in Prostate Cancer,"VANDER GRIEND, DONALD",UNIVERSITY OF CHICAGO,IL,"$91,635"
Prostate Cancer,2016,NCI,3R01CA112226-07S1,,Transcription repression in prostate cancer,"LOGAN, SUSAN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$61,664"
Prostate Cancer,2016,NCI,2U54CA163072-07,6542,Novel mechanisms of SKP2 and AR signaling on the suppression of prostate cancer,"MATUSIK, ROBERT",VANDERBILT UNIVERSITY MEDICAL CENTER,TN,"$101,120"
Prostate Cancer,2016,NCI,2U54CA118948-11,6723,Project 1: CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,"WANG, LIZHONG",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$203,169"
Prostate Cancer,2016,NCI,2U54CA118948-11,6724,Project 2: Molecular Regulation of Kaiso in Prostate Cancer,"YATES, CLAYTON",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$129,359"
Prostate Cancer,2016,NCI,2U54CA163069-06,6964,Novel mechanisms of SKP2 and AR signaling on the suppression of prostate cancer,"CHEN, ZHENBANG",MEHARRY MEDICAL COLLEGE,TN,"$196,848"
Prostate Cancer,2016,NCI,2U54CA118638-11,7113,CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer,"LILLARD, JAMES",MOREHOUSE SCHOOL OF MEDICINE,GA,"$94,154"
Prostate Cancer,2016,NCI,2U54CA118623-11,7188,Full Project 2-Yates and Grizzle,"YATES, CLAYTON",TUSKEGEE UNIVERSITY,AL,"$194,039"
Prostate Cancer,2016,NCI,1R50CA211242-01,,Cellular mechanisms of androgen action and androgen-response gene EAF2 in prostate cancer,"PASCAL, LAURA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$113,935"
Prostate Cancer,2016,NCI,1R50CA211271-01,,Genomics and bioinformatics analysis to understand castration-resistant prostate cancer,"ZHAO, CHANGSHENG",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$139,047"
Prostate Cancer,2016,NCI,3R01CA176671-04S1,,Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET,"LEWIS, JASON",SLOAN-KETTERING INST CAN RESEARCH,NY,"$67,007"
Prostate Cancer,2016,NCI,1F99CA212219-01,,Interrogating the role of non-promoter epigenetic aberrations in cancer,"BHASIN, JEFFREY",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$34,398"
Prostate Cancer,2016,NCI,1F99CA212225-01,,The Role of USP22 in Prostate Cancer Development and Progression,"MCCANN, JENNIFER",THOMAS JEFFERSON UNIVERSITY,PA,"$45,076"
Prostate Cancer,2016,NCI,1F99CA212455-01,,Leveraging polyamine metabolic stress as a novel therapy for prostate cancer,"AFFRONTI, HAYLEY",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$30,550"
Prostate Cancer,2016,NCI,1F99CA212489-01,,System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs,"KIM , HUEN",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$45,076"
Prostate Cancer,2016,NCI,4R00CA181342-03,,Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy,"LIU, PENGDA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$217,518"
Prostate Cancer,2016,NCI,7R01CA070297-18,,Androgen Signaling in prostate cancer progression and CRPC development,"SUN, ZIJIE",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$305,616"
Prostate Cancer,2016,NCI,7R21CA190021-03,,Cellular and Molecular Properties of PINs in Prostate Tumorigenesis,"SUN, ZIJIE",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$221,787"
Prostate Cancer,2016,NCI,7R01CA166894-04,,A New Mechanism for Castration Resistant Prostate Cancer,"SUN, ZIJIE",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$368,984"
Prostate Cancer,2016,NCI,1P20CA202924-01A1,7155,Project 1: Interrogation of novel race-related alternatively spliced androgen receptor target genes in prostate cancer.,"ONYENWOKE, ROB",NORTH CAROLINA CENTRAL UNIVERSITY,NC,"$30,154"
Prostate Cancer,2016,NCI,3R01CA166588-05S1,,"MiR-183-96-182 cluster, prostatic zinc homeostasis and carcinogenesis","NONN, LARISA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$77,860"
Prostate Cancer,2016,NCI,1P20CA202925-01A1,7202,Pilot Project 1,"FREEDMAN, JENNIFER",DUKE UNIVERSITY,NC,"$156,119"
Prostate Cancer,2016,NCI,3R43CA203420-01S1,,Targeting galectin-3 for prostate cancer therapy,"AHMED, HAFIZ","GLYCOMANTRA, INC.",VA,"$40,000"
Prostate Cancer,2016,NCI,3U24CA180918-04S1,,Quantitative Image Informatics for Cancer Research (QIICR),"KIKINIS, RON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$257,375"
Prostate Cancer,2016,NCI,3R01CA197910-02S1,,Chronic inhibition of androgen receptor signaling leads to neuroendocrine prostate cancer by trans differentiation of stem/progenitor cells,"MULHOLLAND, DAVID",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$108,765"
Prostate Cancer,2016,NCI,3R01CA193497-02S1,,The role of MnSOD allelic variations in prostate cancer etiology and outcome,"DIAMOND, ALAN",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$107,563"
Prostate Cancer,2016,NCI,1R41CA206725-01A1,,Novel small-molecule targeted therapy for prostate cancer,"WU, DAQING","METCURE THERAPEUTICS, LLC",GA,"$224,999"
Prostate Cancer,2016,NCI,1R43CA206691-01A1,,A Potent Small Molecule Sigma1 Modulator Degrades Androgen Receptor In Castration Resistant Prostate Cancer,"LEHR, MARTIN","CONTEXT THERAPEUTICS, LLC",PA,"$225,222"
Prostate Cancer,2016,NCI,3R01CA027607-36S1,,Stress Induction of Glucose Regulated Protein GRP78/BiP,"LEE, AMY",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$74,515"
Prostate Cancer,2016,NCI,7U01CA194393-02,,Quantifying and Characterizing the shared genetic contribution to common cancers,"LINDSTROEM, SARA",UNIVERSITY OF WASHINGTON,WA,"$664,391"
Prostate Cancer,2016,OD,3P50CA092131-13S1,,UCLA SPORE in Prostate Cancer,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$100,000"
Prostate Cancer,2016,NCI,3R01CA172495-04S1,,Targeting myristoylation of Src family kinases for inhibition of prostate tumorig,"CAI, HOUJIAN",UNIVERSITY OF GEORGIA,GA,"$48,525"
Prostate Cancer,2016,NCI,3R01CA172495-04S2,,Targeting myristoylation of Src family kinases for inhibition of prostate tumorig,"CAI, HOUJIAN",UNIVERSITY OF GEORGIA,GA,"$48,525"
Prostate Cancer,2016,NCI,3R01CA165574-05S1,,Mechanisms of Hyaluronan Signaling and Turnover in Prostate Cancer,"SIMPSON, MELANIE",UNIVERSITY OF NEBRASKA LINCOLN,NE,"$50,641"
Prostate Cancer,2016,NCI,3R21CA194469-02S1,,The Generation of Clinically Annotated and Molecularly Characterized PDX Animal Models from Racially and Ethnically Diverse Prostate Cancer Tissue,"TURNER, DAVID",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$138,879"
Prostate Cancer,2016,NCI,3R21CA184685-02S1,,Novel gene that determines metastatic phenotype in African-American men,"BHAT, MOHAMMAD SALEEM",UNIVERSITY OF MINNESOTA,MN,"$199,999"
Prostate Cancer,2016,NCI,3R21CA199628-03S1,,Development and Characterization of 3D Organoid Lines from Circulating Tumor Cells of African-American Prostate Cancer Patients,"DEEP, GAGAN",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$199,999"
Prostate Cancer,2016,NIGMS,3R01GM086596-06S1,,Activation of androgen biosynthesis and drug metabolism by cytochrome b5,"AUCHUS, RICHARD",UNIVERSITY OF MICHIGAN,MI,"$217,649"
Prostate Cancer,2016,NIMHD,3G12MD007599-30S1,,Basic and Translational Research Center for Reducing Health Disparities,"ANGULO, JESUS",HUNTER COLLEGE,NY,"$2,619,752"
Prostate Cancer,2016,NCI,5R01CA185251-03,,[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis,"BEEBE, DAVID",UNIVERSITY OF WISCONSIN-MADISON,WI,"$704,248"
Prostate Cancer,2016,NCI,7R01CA172603-04,,A novel strategy to identify prostate cancer biomarkers for patient management,"HUANG, JIAOTI",DUKE UNIVERSITY,NC,"$329,925"
Prostate Cancer,2016,NCI,1U01CA214170-01,,Discovery and qualification of transcriptomic biomarkers for the early detection of aggressive prostate cancer,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN,MI,"$572,443"
Prostate Cancer,2016,NCI,1U01CA214194-01,,Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer,"SEMMES, OLIVER",EASTERN VIRGINIA MEDICAL SCHOOL,VA,"$454,179"
Prostate Cancer,2016,NCI,4P01CA163227-04,6432,Steroid Metabolism in Castration-Resistant Prostate Cancer,"NELSON, PETER",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$312,309"
Prostate Cancer,2016,NCI,4P01CA163227-04,6433,Basis for Androgen Receptor Antagonist Resistance in CRPC,"BALK, STEVEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$293,055"
Prostate Cancer,2016,NCI,4P01CA163227-04,6434,Development of Castration Resistance by Alternative AR Splicing,"PLYMATE, STEPHEN",UNIVERSITY OF WASHINGTON,WA,"$389,080"
Prostate Cancer,2016,NCI,3P01CA098912-12S1,,Prostate Cancer Bone Metastasis Biology and Targeting,"CHUNG, LELAND",CEDARS-SINAI MEDICAL CENTER,CA,"$110,892"
Prostate Cancer,2016,NCI,3U01CA194730-02S1,,MicroRNAs in African American Prostate Cancer,"KUMAR, DEEPAK",UNIVERSITY OF THE DISTRICT OF COLUMBIA,DC,"$61,583"
Prostate Cancer,2016,NCI,7U01CA188392-03,,Imputation-based approach to identify low frequency variants in prostate cancer,"SCHUMACHER, FREDRICK",CASE WESTERN RESERVE UNIVERSITY,OH,"$603,954"
Prostate Cancer,2016,NINR,7R01NR014518-03,,Staying Strong and Healthy for Androgen Deprivation Therapy for Latino Men,"MALISKI, SALLY",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$621,547"
Prostate Cancer,2016,NCI,ACN15006001-1-0-1,,NCI Early Detection Research Network:  Biomarker Reference and Resource Center (BRRC),NO PI IDENTIFIED,NIH,,"$800,000"
Prostate Cancer,2016,NCI,ACN12011001-1-0-1,,EDRN Biomarker Reference Laboratory,NO PI IDENTIFIED,NIH,,"$459,666"
Prostate Cancer,2016,NCI,3U54CA096300-14S1,,UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2),"LOPEZ-BERESTEIN, GABRIEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$72,364"
Prostate Cancer,2016,NCI,3U54CA096297-14S1,,UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2),"CRUZ-CORREA, MARCIA",UNIVERSITY OF PUERTO RICO MED SCIENCES,PR,"$217,227"
Prostate Cancer,2016,NCI,3U54CA155496-05S1,,A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE,"COLDITZ, GRAHAM",WASHINGTON UNIVERSITY,MO,"$401,250"
Prostate Cancer,2016,NCI,261201200031I-3-26100006-1,,"402 -- TITLE: PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROSTVAC (PSA-TRICOM) IN PATIENTS... (PROTOCOL UAZ2012-03-01). CONTRACTOR: UNIVERSITY OF ARIZONA. CONTRACT: HHSN261201200031I. PERIOD: 9","CHOW, SHERY",UNIVERSITY OF ARIZONA,AZ,"$948,936"
Prostate Cancer,2016,NCI,3P50CA097186-14S1,7590,Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$223,285"
Prostate Cancer,2016,NCI,3P50CA097186-14S1,7595,Clinical,"YU, EVAN",UNIVERSITY OF WASHINGTON,WA,"$522,676"
Prostate Cancer,2016,NCI,1ZIACP010121-21,,Molecular Epidemiology Studies of Occupational and Environmental Exposures,"ROTHMAN, NATHANIEL",NIH,,"$979,771"
Prostate Cancer,2016,NCI,1ZIACP010152-17,,PLCO Trial Etiologic and Early Marker Study,"HOOVER, ROBERT",NIH,,"$2,752,961"
Prostate Cancer,2016,NCI,1ZIACP010169-15,,"Nutrition, Metabolism, and Cancer","ZIEGLER, REGINA",NIH,,"$641,119"
Prostate Cancer,2016,NCI,1ZIACP010180-15,,Prostate Cancer Studies,"COOK, MICHAEL",NIH,,"$676,908"
Prostate Cancer,2016,NCI,1ZIACP010183-14,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$155,385"
Prostate Cancer,2016,NCI,1ZIACP010184-14,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$1,770,645"
Prostate Cancer,2016,NCI,1ZIACP010187-12,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$169,781"
Prostate Cancer,2016,NCI,1ZIACP010207-07,,PLCO EEMS and Extended Follow Up,"HOOVER, ROBERT",NIH,,"$706,495"
Prostate Cancer,2016,NCI,1ZIACP010221-06,,Etiologic Studies of Prostate Cancer,"ALBANES, DEMETRIUS",NIH,,"$388,106"
Prostate Cancer,2016,NIEHS,1ZICES102545-09,,DNA Sequencing,"ARCHER, TREVOR",NIH,,"$1,282,822"
Prostate Cancer,2016,NCI,1ZIABC010425-17,,Strategies for Cancer Immunotherapy Clinical Trials,"SCHLOM, JEFFREY",NIH,,"$584,740"
Prostate Cancer,2016,NCI,1ZIABC010453-15,,Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,"FIGG, WILLIAM",NIH,,"$642,672"
Prostate Cancer,2016,NCI,1ZIABC010499-14,,Maryland Prostate Cancer Case-Control Study,"AMBS, STEFAN",NIH,,"$623,251"
Prostate Cancer,2016,NCI,1ZIABC010547-14,,Development of Drugs That Target Prostate Cancer,"FIGG, WILLIAM",NIH,,"$482,004"
Prostate Cancer,2016,NCI,1ZIABC010607-13,,Ras-mediated signals in human epithelial cell transformation and metastasis,"KELLY, KATHLEEN",NIH,,"$586,874"
Prostate Cancer,2016,NCI,1ZIABC010624-13,,The Molecular Profile of Prostate Tumors in African-American Men,"AMBS, STEFAN",NIH,,"$356,143"
Prostate Cancer,2016,NCI,1ZIABC010627-13,,Clinical Pharmacogenetics,"FIGG, WILLIAM",NIH,,"$755,672"
Prostate Cancer,2016,NCI,1ZIABC010655-12,,Prostate Cancer Imaging,"CHOYKE, PETER",NIH,,"$2,890,058"
Prostate Cancer,2016,NCI,1ZIABC010666-12,,Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"GULLEY, JAMES",NIH,,"$787,127"
Prostate Cancer,2016,NCI,1ZIABC010802-10,,Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,"KELLY, KATHLEEN",NIH,,"$978,122"
Prostate Cancer,2016,NCI,1ZIABC010834-10,,"Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer","RIED, THOMAS",NIH,,"$560,918"
Prostate Cancer,2016,NCI,1ZIABC010886-09,,Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,"AMBS, STEFAN",NIH,,"$89,035"
Prostate Cancer,2016,NCI,1ZIABC010945-09,,Clinical trials employing cancer vaccine combination therapies,"GULLEY, JAMES",NIH,,"$787,127"
Prostate Cancer,2016,NCI,1ZIABC010973-09,,Analyses of human T regulatory cells,"TSANG, KWONG YOK",NIH,,"$617,092"
Prostate Cancer,2016,NCI,1ZIABC011053-09,,TMPRSS2-ERG chromosomal translocations and prostate cancer,"KELLY, KATHLEEN",NIH,,"$195,624"
Prostate Cancer,2016,NCI,1ZIABC011055-09,,Serum Antibody Profiling with a Carbohydrate Microarray,"GILDERSLEEVE, JEFF",NIH,,"$423,701"
Prostate Cancer,2016,NCI,1ZIABC011081-09,,Prostate Section,"PINTO, PETER",NIH,,"$555,067"
Prostate Cancer,2016,NCI,1ZIABC011307-07,,Self-assembling protoviral nanoparticles,"TARASOVA, NADYA",NIH,,"$380,215"
Prostate Cancer,2016,NCI,1ZIABC011406-06,,miRNA profiling  of prostate cancer in young and older male patients,"MERINO, MARIA",NIH,,"$205,263"
Prostate Cancer,2016,NCI,1ZIABC011552-03,,Targeting mechanisms of radiation resistance,"CITRIN, DEBORAH",NIH,,"$542,797"
Prostate Cancer,2016,NCI,1ZIABC011679-01,,Mechanisms driving evolution of aggressive prostate cancer,"SOWALSKY, ADAM",NIH,,"$644,154"
Prostate Cancer,2016,NCI,1ZIABC011680-01,,Early detection of prostate cancer using circulating tumor DNA,"SOWALSKY, ADAM",NIH,,"$644,154"
Prostate Cancer,2016,NCI,1ZIABC011713-01,,Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer,"VANDERWEELE, DAVID",NIH,,"$690,899"
Prostate Cancer,2016,NCI,1ZIABC011719-01,,Multiregion sequencing of localized prostate cancer,"VANDERWEELE, DAVID",NIH,,"$36,363"
Prostate Cancer,2016,NCI,1ZIASC004020-39,,"Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","BERZOFSKY, JAY",NIH,,"$3,386,683"
Prostate Cancer,2016,NCI,1ZIASC006538-23,,Development of Angiogenesis Inhibitors,"FIGG, WILLIAM",NIH,,"$482,004"
Prostate Cancer,2016,NCI,1ZIASC009389-23,,A Mitogen-induced G Protein-coupled Receptor,"KELLY, KATHLEEN",NIH,,"$195,624"
Prostate Cancer,2016,NCI,1ZIASC010098-14,,The Evaluation of Novel Therapeutics for Genitourinary Malignancies,"DAHUT, WILLIAM",NIH,,"$929,563"
Prostate Cancer,2016,NCI,1ZICBC010947-09,,Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility,"LAKE, ROSS",NIH,,"$861,527"
Prostate Cancer,2016,NCI,1ZICBC011044-09,,Tissue Processing-Sequencing Facility,"VOCKE, CATHY",NIH,,"$648,227"
Prostate Cancer,2016,NCI,1ZICBC011047-09,,Animal Model and Genotyping Core Support Facility,"DU BOIS, WENDY",NIH,,"$1,475,369"
Prostate Cancer,2016,NCI,1ZICSC006743-23,,Signal Transduction Events and the Regulation of Cell Growth,"TREPEL, JANE",NIH,,"$870,159"
Prostate Cancer,2016,NCI,1ZIDBC011089-09,,Clinical Nursing and Data Management Core,"LINEHAN, WILLIAM",NIH,,"$1,127,936"
Prostate Cancer,2016,NCI,7R01CA155693-06,,Decoding NanogP8 in Tumorigenesis,"TANG, DEAN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$253,216"
Prostate Cancer,2016,NIEHS,1ZIAES103308-02,,Application of Statistical Methods in Epidemiology Studies,"ZHAO, SHANSHAN",NIH,,"$62,876"
Prostate Cancer,2016,NCI,3R01CA174453-04S1,,PROMIS Validation in Prospective Population-based Prostate Cancer Research Study,"REEVE, BRYCE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$150,000"
Prostate Cancer,2016,NCI,261201600015C-0-0-1,,IGF::OT::IGF TARGETED RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS USING PB212-OCTREOTATE ANALOGS,"TWOROWSKA, IZABELA","RADIOMEDIX, INC.",TX,"$298,132"
Prostate Cancer,2016,NCI,261201600016C-0-0-1,,IGF::OT::IGF PROSTATE CANCER SELECTIVE RADIOACTIVE PRODRUG,"KASSIS, AMIN","ONCOTHERAPEUTICA, INC.",MA,"$298,882"
Prostate Cancer,2016,NCI,261201600027C-0-0-1,,IGF::OT::IGF PREDICTIVE BIOMARKERS OF PROSTATE CANCER PATIENT SENSITIVITY FOR RADIATION LATE EFFECTS,"GRINDROD, PHD, SCOTT","SHUTTLE PHARMACEUTICALS, LLC",MD,"$299,502"
Prostate Cancer,2016,NCI,261201600063C-0-0-1,,IGF::OT::IGF PREDICTIVE BIOMARKERS OF ADVERSE REACTIONS TO RADIATION TREATMENT POP: 9/19/16 - 6/18/17,"ZHANG, AIGUO","DIACARTA, LLC",CA,"$299,698"
Prostate Cancer,2016,NCI,261201500074C-4-0-2,,IGF::OT::IGF  DEVELOPMENT OF AN INNOVATIVE PSMA-TARGETED RADIONUCLIDE THERAPY FOR PROSTATE CANCER. PERIOD OF PERFORMANCE: 09/30/2015 - 02/28/2018.,"LANGTON-WEBSTER, BEATRICE","CANCER TARGETED TECHNOLOGY, LLC",WA,"$2,000,000"
Prostate Cancer,2016,NIDDK,1ZIAHL006003-09,,Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ,"RODGERS, GRIFFIN",NIH,,"$570,763"
Prostate Cancer,2016,NCI,261201600038C-0-0-1,,IGF::OT::IGF SBIR PHASE I TOPIC 352 CELL-BASED MODELS FOR PROSTATE CANCER HEALTH DISPARITY RESEARCH,"RHIM, JOHNG","SHUTTLE PHARMACEUTICALS, LLC",MD,"$224,687"
Prostate Cancer,2016,NHGRI,1ZIAHG200325-12,,Finding Genes for Human Prostate Cancer,"OSTRANDER, ELAINE",NIH,,"$1,116,252"
Prostate Cancer,2016,NHGRI,1ZIAHG200331-12,,Genetic Epidemiology of Cancer,"BAILEY-WILSON, JOAN",NIH,,"$746,567"
Prostate Cancer,2016,NHGRI,1ZIAHG200366-07,,Germline modifiers of tumor progression and metastasis in prostate cancer,"CRAWFORD, NIGEL",NIH,,"$1,107,427"
Prostate Cancer,2016,NLM,1ZIALM010008-01,,Clinical and Informatics Research on Large Clinical Databases,"BAIK, SEO",NIH,,"$398,028"
Prostate Cancer,2016,RMAP,1ZIATR000243-02,,Targeting Tumor-derived exRNA-Containing microvesicles by high throughput screening,"FERRER, MARC",NIH,,"$158,000"
Prostate Cancer,2016,NCI,261201500038I-0-26100005-1,,IGF::OT::IGF PROSTATE CANCER PREVENTION BY ASPIRIN AND/OR OTHER NSAIDS TORFP 2016-E03HHSN2612015000381PERIOD OF PERFORMANCE: 07/07/2016 - 03/06/2019,"RAO, CHINTHALAPALLY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$625,093"
Prostate Cancer,2016,NCI,ACN16001001-1-0-1,,Nutrient Interaction in Prostate Cancer Cells:  Effects of I3C/DIM on AhR-mediated pathway,"WANG, PHD, TOM",NIH,,"$65,000"
Prostate Cancer,2016,NCI,261201600007I-0-26100002-1,,IGF::OT::IGF CENTRAL DATA COLLECTION CENTER (CDCC)QUESTIONNAIRE AND BUCCAL CELL PROJECT. PERIOD OF PERFORMANCE: 09/19/2016 TO 09/18/2019,"MATHEW, SUNITHA","WESTAT, INC.",MD,"$930,760"
